AU2013211535A1 - Antimicrobial compositions and methods - Google Patents
Antimicrobial compositions and methods Download PDFInfo
- Publication number
- AU2013211535A1 AU2013211535A1 AU2013211535A AU2013211535A AU2013211535A1 AU 2013211535 A1 AU2013211535 A1 AU 2013211535A1 AU 2013211535 A AU2013211535 A AU 2013211535A AU 2013211535 A AU2013211535 A AU 2013211535A AU 2013211535 A1 AU2013211535 A1 AU 2013211535A1
- Authority
- AU
- Australia
- Prior art keywords
- composition
- antimicrobial
- group
- enhancer
- combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 259
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 168
- 238000000034 method Methods 0.000 title claims abstract description 63
- 239000003623 enhancer Substances 0.000 claims abstract description 109
- 150000002632 lipids Chemical class 0.000 claims abstract description 72
- 239000004094 surface-active agent Substances 0.000 claims abstract description 40
- 239000004599 antimicrobial Substances 0.000 claims abstract description 37
- 235000000346 sugar Nutrition 0.000 claims abstract description 32
- 108010062877 Bacteriocins Proteins 0.000 claims abstract description 25
- 102000008133 Iron-Binding Proteins Human genes 0.000 claims abstract description 24
- 108010035210 Iron-Binding Proteins Proteins 0.000 claims abstract description 24
- 150000008163 sugars Chemical class 0.000 claims abstract description 21
- 239000000589 Siderophore Substances 0.000 claims abstract description 20
- 102000004190 Enzymes Human genes 0.000 claims abstract description 19
- 108090000790 Enzymes Proteins 0.000 claims abstract description 19
- 239000004753 textile Substances 0.000 claims abstract description 7
- 150000005846 sugar alcohols Polymers 0.000 claims description 99
- -1 fatty acid ester Chemical class 0.000 claims description 85
- 239000000194 fatty acid Substances 0.000 claims description 84
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 83
- 229930195729 fatty acid Natural products 0.000 claims description 83
- 238000009472 formulation Methods 0.000 claims description 62
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 60
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 58
- 150000001875 compounds Chemical class 0.000 claims description 46
- 150000002195 fatty ethers Chemical class 0.000 claims description 41
- 150000004665 fatty acids Chemical class 0.000 claims description 30
- 108010053775 Nisin Proteins 0.000 claims description 27
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 claims description 26
- 239000004309 nisin Substances 0.000 claims description 26
- 235000010297 nisin Nutrition 0.000 claims description 26
- 235000013372 meat Nutrition 0.000 claims description 25
- 239000000758 substrate Substances 0.000 claims description 24
- 108010063045 Lactoferrin Proteins 0.000 claims description 21
- 102000010445 Lactoferrin Human genes 0.000 claims description 21
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 21
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 20
- 229940078795 lactoferrin Drugs 0.000 claims description 20
- 235000021242 lactoferrin Nutrition 0.000 claims description 20
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 18
- 150000007524 organic acids Chemical class 0.000 claims description 15
- 230000009467 reduction Effects 0.000 claims description 14
- 210000000214 mouth Anatomy 0.000 claims description 12
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 11
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 11
- 239000000811 xylitol Substances 0.000 claims description 11
- 235000010447 xylitol Nutrition 0.000 claims description 11
- 229960002675 xylitol Drugs 0.000 claims description 11
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 11
- 239000005711 Benzoic acid Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 235000010233 benzoic acid Nutrition 0.000 claims description 10
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 9
- 229930195725 Mannitol Natural products 0.000 claims description 9
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 9
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 9
- 239000000594 mannitol Substances 0.000 claims description 9
- 235000010355 mannitol Nutrition 0.000 claims description 9
- 239000011521 glass Substances 0.000 claims description 8
- 229920006395 saturated elastomer Polymers 0.000 claims description 8
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 7
- 235000013622 meat product Nutrition 0.000 claims description 7
- 238000007865 diluting Methods 0.000 claims description 5
- 239000002023 wood Substances 0.000 claims description 5
- 241001148470 aerobic bacillus Species 0.000 claims description 4
- 150000004703 alkoxides Chemical class 0.000 claims description 4
- 229920001971 elastomer Polymers 0.000 claims description 4
- 150000002772 monosaccharides Chemical group 0.000 claims description 4
- 150000002989 phenols Chemical class 0.000 claims description 4
- 239000005060 rubber Substances 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 235000010356 sorbitol Nutrition 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- 229960001855 mannitol Drugs 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims 9
- 229940023487 dental product Drugs 0.000 claims 3
- 239000002184 metal Substances 0.000 claims 3
- 229910052751 metal Inorganic materials 0.000 claims 3
- QBUKAFSEUHGMMX-MTJSOVHGSA-N (5z)-5-[[3-(1-hydroxyethyl)thiophen-2-yl]methylidene]-10-methoxy-2,2,4-trimethyl-1h-chromeno[3,4-f]quinolin-9-ol Chemical compound C1=CC=2NC(C)(C)C=C(C)C=2C2=C1C=1C(OC)=C(O)C=CC=1O\C2=C/C=1SC=CC=1C(C)O QBUKAFSEUHGMMX-MTJSOVHGSA-N 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 abstract description 12
- 230000008569 process Effects 0.000 abstract description 8
- 238000011109 contamination Methods 0.000 abstract description 5
- 235000012055 fruits and vegetables Nutrition 0.000 abstract description 5
- 239000005416 organic matter Substances 0.000 abstract description 4
- 150000001298 alcohols Chemical class 0.000 abstract description 3
- 235000020991 processed meat Nutrition 0.000 abstract description 3
- 229910001220 stainless steel Inorganic materials 0.000 abstract description 2
- 239000010935 stainless steel Substances 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 description 56
- 241000196324 Embryophyta Species 0.000 description 38
- 241000894006 Bacteria Species 0.000 description 32
- 235000015278 beef Nutrition 0.000 description 26
- 239000000243 solution Substances 0.000 description 23
- 235000011187 glycerol Nutrition 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 239000012141 concentrate Substances 0.000 description 18
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 18
- 239000000463 material Substances 0.000 description 17
- ARIWANIATODDMH-UHFFFAOYSA-N Lauric acid monoglyceride Natural products CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 15
- 244000005700 microbiome Species 0.000 description 15
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 239000003981 vehicle Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 12
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 12
- 150000002148 esters Chemical class 0.000 description 11
- 238000002156 mixing Methods 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 10
- ARIWANIATODDMH-AWEZNQCLSA-N 1-lauroyl-sn-glycerol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)CO ARIWANIATODDMH-AWEZNQCLSA-N 0.000 description 9
- 241000233866 Fungi Species 0.000 description 9
- 229930006000 Sucrose Natural products 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 239000005720 sucrose Substances 0.000 description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- 239000007921 spray Substances 0.000 description 8
- 108010078777 Colistin Proteins 0.000 description 7
- 241000700605 Viruses Species 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 description 7
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- AMJZVHHOVFFTOM-UHFFFAOYSA-M sodium;2-(2-hexanoyloxypropanoyloxy)propanoate Chemical compound [Na+].CCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O AMJZVHHOVFFTOM-UHFFFAOYSA-M 0.000 description 7
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 7
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 6
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- GHHURQMJLARIDK-UHFFFAOYSA-N 2-hydroxypropyl octanoate Chemical compound CCCCCCCC(=O)OCC(C)O GHHURQMJLARIDK-UHFFFAOYSA-N 0.000 description 5
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 5
- 239000005639 Lauric acid Substances 0.000 description 5
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 5
- 241000194019 Streptococcus mutans Species 0.000 description 5
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229960003346 colistin Drugs 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 244000052637 human pathogen Species 0.000 description 5
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- 241000192125 Firmicutes Species 0.000 description 4
- 108090000988 Lysostaphin Proteins 0.000 description 4
- 229920002066 Pluronic® P 65 Polymers 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 4
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 239000000645 desinfectant Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical group COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LKUNXBRZDFMZOK-GFCCVEGCSA-N Capric acid monoglyceride Natural products CCCCCCCCCC(=O)OC[C@H](O)CO LKUNXBRZDFMZOK-GFCCVEGCSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 241000186779 Listeria monocytogenes Species 0.000 description 3
- 241000204031 Mycoplasma Species 0.000 description 3
- 241000589516 Pseudomonas Species 0.000 description 3
- KZENBFUSKMWCJF-UHFFFAOYSA-N [5-[5-[5-(hydroxymethyl)-2-thiophenyl]-2-furanyl]-2-thiophenyl]methanol Chemical compound S1C(CO)=CC=C1C1=CC=C(C=2SC(CO)=CC=2)O1 KZENBFUSKMWCJF-UHFFFAOYSA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- PHMQYKDOTWAOBI-UHFFFAOYSA-N decanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCC(O)=O PHMQYKDOTWAOBI-UHFFFAOYSA-N 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 150000002016 disaccharides Chemical class 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 229910001447 ferric ion Inorganic materials 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 3
- LKUNXBRZDFMZOK-UHFFFAOYSA-N rac-1-monodecanoylglycerol Chemical compound CCCCCCCCCC(=O)OCC(O)CO LKUNXBRZDFMZOK-UHFFFAOYSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- OXLXSOPFNVKUMU-UHFFFAOYSA-N 1,4-dioctoxy-1,4-dioxobutane-2-sulfonic acid Chemical class CCCCCCCCOC(=O)CC(S(O)(=O)=O)C(=O)OCCCCCCCC OXLXSOPFNVKUMU-UHFFFAOYSA-N 0.000 description 2
- GBXRUYNQDDTQQS-UHFFFAOYSA-N 1-O-dodecylglycerol Chemical compound CCCCCCCCCCCCOCC(O)CO GBXRUYNQDDTQQS-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- QNPZYUBXQSQEEC-UHFFFAOYSA-N 2,3-dihydroxyundecan-4-one Chemical compound CCCCCCCC(=O)C(O)C(C)O QNPZYUBXQSQEEC-UHFFFAOYSA-N 0.000 description 2
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 2
- GUPXYSSGJWIURR-UHFFFAOYSA-N 3-octoxypropane-1,2-diol Chemical compound CCCCCCCCOCC(O)CO GUPXYSSGJWIURR-UHFFFAOYSA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193755 Bacillus cereus Species 0.000 description 2
- 108010061075 Enterobactin Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 208000019331 Foodborne disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 241000589989 Helicobacter Species 0.000 description 2
- 240000004658 Medicago sativa Species 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 206010041925 Staphylococcal infections Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 102000004338 Transferrin Human genes 0.000 description 2
- 108090000901 Transferrin Proteins 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000008135 aqueous vehicle Substances 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 2
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical class CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 2
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical class CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- SERBHKJMVBATSJ-BZSNNMDCSA-N enterobactin Chemical compound OC1=CC=CC(C(=O)N[C@@H]2C(OC[C@@H](C(=O)OC[C@@H](C(=O)OC2)NC(=O)C=2C(=C(O)C=CC=2)O)NC(=O)C=2C(=C(O)C=CC=2)O)=O)=C1O SERBHKJMVBATSJ-BZSNNMDCSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000019249 food preservative Nutrition 0.000 description 2
- 239000005452 food preservative Substances 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- 235000020993 ground meat Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- 235000019692 hotdogs Nutrition 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- YKQOSKADJPQZHB-YNWHQGOSSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1s)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Polymers CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O YKQOSKADJPQZHB-YNWHQGOSSA-N 0.000 description 2
- 239000002687 nonaqueous vehicle Substances 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 244000000003 plant pathogen Species 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- NYBZAGXTZXPYND-GBIKHYSHSA-N pyochelin I Chemical compound S1C[C@@H](C(O)=O)N(C)[C@H]1[C@@H]1N=C(C=2C(=CC=CC=2)O)SC1 NYBZAGXTZXPYND-GBIKHYSHSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
- NTYZDAJPNNBYED-UHFFFAOYSA-M sodium;2-(2-dodecanoyloxypropanoyloxy)propanoate Chemical compound [Na+].CCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O NTYZDAJPNNBYED-UHFFFAOYSA-M 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 150000005691 triesters Chemical class 0.000 description 2
- 239000001974 tryptic soy broth Substances 0.000 description 2
- 108010050327 trypticase-soy broth Proteins 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- XDIYNQZUNSSENW-KZXKDKCNSA-N (2s,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O XDIYNQZUNSSENW-KZXKDKCNSA-N 0.000 description 1
- GBKVAPJMXMGXJK-NSHDSACASA-N (4R)-2-(2,3-dihydroxyphenyl)-N-hydroxy-N-[2-(1H-imidazol-5-yl)ethyl]-4,5-dihydro-1,3-thiazole-4-carboxamide Chemical compound ON(CCc1cnc[nH]1)C(=O)[C@@H]1CSC(=N1)c1cccc(O)c1O GBKVAPJMXMGXJK-NSHDSACASA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- KVZLHPXEUGJPAH-UHFFFAOYSA-N 2-oxidanylpropanoic acid Chemical compound CC(O)C(O)=O.CC(O)C(O)=O KVZLHPXEUGJPAH-UHFFFAOYSA-N 0.000 description 1
- IXTLVPXCZJJUQB-VYJQSIGYSA-N 4-[[1-[[(2r)-1-[[(2s)-5-(diaminomethylideneamino)-1-[[(2r)-1-[[(2s)-5-[formyl(hydroxy)amino]-1-[[(3s,6s,9s,12s)-9-[3-[formyl(hydroxy)amino]propyl]-3,6-bis[(1r)-1-hydroxyethyl]-2,5,8,11-tetraoxo-1,4,7,10-tetrazacyclohexadec-12-yl]amino]-1-oxopentan-2-yl]am Chemical compound C1CCCNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCN(O)C=O)NC(=O)[C@H]1NC(=O)[C@H](CCCN(O)C=O)NC(=O)[C@@H](CO)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CO)NC(=O)C1N(C=2C(=CC(O)=C(O)C=2)C=C2NC(=O)CCC(O)=O)C2NCC1 IXTLVPXCZJJUQB-VYJQSIGYSA-N 0.000 description 1
- AWQSAIIDOMEEOD-UHFFFAOYSA-N 5,5-Dimethyl-4-(3-oxobutyl)dihydro-2(3H)-furanone Chemical compound CC(=O)CCC1CC(=O)OC1(C)C AWQSAIIDOMEEOD-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241001465180 Botrytis Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 108010073254 Colicins Proteins 0.000 description 1
- 241000222199 Colletotrichum Species 0.000 description 1
- 244000180278 Copernicia prunifera Species 0.000 description 1
- 235000010919 Copernicia prunifera Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000009849 Cucumis sativus Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- SERBHKJMVBATSJ-UHFFFAOYSA-N Enterobactin Natural products OC1=CC=CC(C(=O)NC2C(OCC(C(=O)OCC(C(=O)OC2)NC(=O)C=2C(=C(O)C=CC=2)O)NC(=O)C=2C(=C(O)C=CC=2)O)=O)=C1O SERBHKJMVBATSJ-UHFFFAOYSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 1
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 1
- KDHHWXGBNUCREU-HOTGVXAUSA-N Ferric-aerobactin Chemical compound CC(=O)N(O)CCCC[C@@H](C(O)=O)NC(=O)CC(O)(C(O)=O)CC(=O)N[C@H](C(O)=O)CCCCN(O)C(C)=O KDHHWXGBNUCREU-HOTGVXAUSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241001251094 Formica Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- DWPCPZJAHOETAG-IMJSIDKUSA-N L-lanthionine Chemical compound OC(=O)[C@@H](N)CSC[C@H](N)C(O)=O DWPCPZJAHOETAG-IMJSIDKUSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 101800004361 Lactoferricin-B Proteins 0.000 description 1
- 101800004366 Lactoferricin-H Proteins 0.000 description 1
- 102400000839 Lactoferricin-H Human genes 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 229930183781 Mycobactin Natural products 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241001263478 Norovirus Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000588701 Pectobacterium carotovorum Species 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 241001503951 Phoma Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- NYBZAGXTZXPYND-UHFFFAOYSA-N Pyochelin I Natural products S1CC(C(O)=O)N(C)C1C1N=C(C=2C(=CC=CC=2)O)SC1 NYBZAGXTZXPYND-UHFFFAOYSA-N 0.000 description 1
- 229930186551 Pyoverdin Natural products 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000271567 Struthioniformes Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- NGHUOSKIZOQGBY-PMDAXIHYSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-[2,3-bis[[(Z)-octadec-9-enoyl]oxy]propoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(COC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC NGHUOSKIZOQGBY-PMDAXIHYSA-N 0.000 description 1
- CUPCBVUMRUSXIU-UHFFFAOYSA-N [Fe].OOO Chemical class [Fe].OOO CUPCBVUMRUSXIU-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 108010019306 anguibactin Proteins 0.000 description 1
- GBKVAPJMXMGXJK-UHFFFAOYSA-N anguibactin Natural products ON(CCc1cnc[nH]1)C(=O)C1CSC(=N1)c1cccc(O)c1O GBKVAPJMXMGXJK-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003916 calcium stearoyl-2-lactylate Substances 0.000 description 1
- 235000010957 calcium stearoyl-2-lactylate Nutrition 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 238000010611 checkerboard assay Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000005548 dental material Substances 0.000 description 1
- 239000000551 dentifrice Substances 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000011037 discontinuous sequential dilution Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000504 effect on taste Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 108010013932 exochelins Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 125000005644 linolenyl group Chemical group 0.000 description 1
- 125000005645 linoleyl group Chemical group 0.000 description 1
- 235000021156 lunch Nutrition 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- DWPCPZJAHOETAG-UHFFFAOYSA-N meso-lanthionine Natural products OC(=O)C(N)CSCC(N)C(O)=O DWPCPZJAHOETAG-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- XZGYBQIQSLSHDH-COEJQBHMSA-N mycobactin Chemical compound C1CCCN(O)C(=O)C1NC(=O)C(C)C(CC)OC(=O)C(CCCCN(O)C(=O)\C=C/CCCCCCCCCCCCCCC)NC(=O)C(N=1)COC=1C1=C(C)C=CC=C1O XZGYBQIQSLSHDH-COEJQBHMSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000014594 pastries Nutrition 0.000 description 1
- 108010049023 pediocin PA-1 Proteins 0.000 description 1
- FLTWKHKMXZLDNR-CVMNUACMSA-N pediocin ach Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)OC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1N=CN=C1)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](N)CCCCN)C(C)C)[C@@H](C)O)C1C=NC=N1 FLTWKHKMXZLDNR-CVMNUACMSA-N 0.000 description 1
- PIKNPBDDTPJRGQ-UHFFFAOYSA-N pentadec-2-ene Chemical group CCCCCCCCCCCCC=CC PIKNPBDDTPJRGQ-UHFFFAOYSA-N 0.000 description 1
- ZRXBXUXGFXPQTD-UHFFFAOYSA-N pentadecane-2,3-diol Chemical compound CCCCCCCCCCCCC(O)C(C)O ZRXBXUXGFXPQTD-UHFFFAOYSA-N 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000004707 phenolate Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 235000013613 poultry product Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108010025281 pyoverdin Proteins 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 235000020612 ready-to-feed formula Nutrition 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000014438 salad dressings Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 1
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 description 1
- 239000003724 sodium stearoyl-2-lactylate Substances 0.000 description 1
- 235000010956 sodium stearoyl-2-lactylate Nutrition 0.000 description 1
- GDIUOQQOLKSNCD-UHFFFAOYSA-M sodium;2-(2-docosanoyloxypropanoyloxy)propanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O GDIUOQQOLKSNCD-UHFFFAOYSA-M 0.000 description 1
- FOSNFLMXYRQNAF-UHFFFAOYSA-M sodium;2-[2-(16-methylheptadecanoyloxy)propanoyloxy]propanoate Chemical compound [Na+].CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O FOSNFLMXYRQNAF-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- LLMKLMMXMOTPRU-YOAXHERRSA-N vibriobactin Chemical compound O=C([C@@H]1N=C(O[C@H]1C)C=1C(=C(O)C=CC=1)O)NCCCN(C(=O)[C@@H]1[C@H](OC(=N1)C=1C(=C(O)C=CC=1)O)C)CCCNC(=O)C1=CC=CC(O)=C1O LLMKLMMXMOTPRU-YOAXHERRSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/06—Oxygen or sulfur directly attached to a cycloaliphatic ring system
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Abstract
Docun tl-2/08/2013 ANTIMICROBIAL COMPOSITION AND METHODS The present invention is generally related to a product and process to reduce the microbial 5 contamination on organic matter, such as processed meat, fruits and vegetables, plant parts, inanimate surfaces such as textiles and stainless steel, and in the mount or on dental products. In particular, the invention is related to a product and process to disinfect surfaces using an antimicrobial composition containing an antimicrobial lipid, an enhancer selected from the group consisting of bacteriocins, antimicrobial enzymes, sugars, sugar 10 alcohols, iron-binding proteins and derivatives thereof, siderophores, and combinations thereof, and optionally a surfactant.
Description
-1- ANTIMICROBIAL COMPOSITIONS AND METHODS FIELD OF THE INVENTION The present inverdion is generally related to a composition and method to 5 reduce the microbial contamination on organic matter, such as processed meat, fruits and vegetables, plant parts; and other inanimate surfaces such as textiles and stainless steel. Such compositions can also be used in dental applications to reduce the microbial concentration in the mouth, for example. 10 BACKGROUND Food borne diseases cause significant illness and death each year, with direct and indirect medical costs estimated by some sources to be over I billion a year. Common food pathogens include Salmonella, Listeria monocytogenes, Escherichia coli 0157:1H7, Campylolacterjejuni, Bacillus cereus, and Norwalk-like viruses. Outbreaks L 5 of food bome diseases typically have been associated with-contaminated meat products, raw milk, or poultry products but fruits and vegetables can also serve as sources of food borne illness. Surfaces, containers, and other substrates can be a source of contamination in food. Recalls of food products, such as ground beef, hot dogs, alfalfa sprouts, and orange juice, show a need for a broad spectrum antimicrobial solution that !0 is food grade, and cost effective. Compositions used to reduce the microbial contamination in and on food as well as other surfaces have typically involved use of materials such as organic acids and chlorine compounds, such as sodium hypochlorite, that at higher concentrations may affect the properties of the surface treated. Compositions using fatty acid monoesters 25 have been used in recent years to reduce microbial load on food such as poultry, as described in U.S. Patent Nos. 5,460,833 and 5,490,992, and fruit and vegetables, as described in International PublicationNo. WO 200143549A. Fatty acid monoesters have also been used in dried compositions on textiles, as described in Applicants' Assignee's Co-pending U.S. Patent Application Serial No. 091572,549, filed on 30 May 17, 2000. They have alsodbeen used on contact lenses, as described in U.S. Patent No. 4,485,029. The fatty acid monoesters in these compositions have limited stability in the presence of other components.
-2 U.S. Patent No. 5,804,549 discloses compositions consisting essentially of the lanthionine containing bacteriocin, nisin in combination with glycerol monolaurate, and the use of such composition for the treatment of bacterial infections of the genus Helicobacter. These formulations are directed to treatment in the gastrointestinal tract 5 by affecting the mucous system that protects the microbes. SUMMARY The present invention provides compositions having effective antimicrobial activity for reducing levels of microorganisms on organic matter such as food, 10 mammalian skin, and within the mouth (i.e., oral cavity), and/or on inanimate materials. Compositions of the present invention include an antimicrobial lipid selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof (of either the ester or ether), and combinations thereof. These compositions further include an enhancer. Suitable 15 enhancers may include, but may not be limited to, bacteriocins, antimicrobial enzymes, sugars, sugar alcohols, iron-binding proteins and derivatives thereof, siderophores, and combinations thereof Various combinations of enhancers can be used if desired. Other components that can be included in compositions of the present invention are surfactants, and other additives, in various combinations. The compositions may be W0 used in concentrated form or further combined in either an aqueous or nonaqueous vehicle before use if desired. In one aspect, the present invention provides an antimicrobial'composition that includes: an antimicrobial lipid component that includes a compound selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a 25 polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof; and an enhancer component that includes a compound selected from the group consisting of iron-binding proteins and derivatives thereof, siderophores, and combinations thereof. In another aspect the present invention provides an antimicrobial composition that includes: an antimicrobial lipid component that includes a compound selected 30 from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof; and an enhancer component that includes an organic acid and a compound selected from the vv Ws &u.jva.ryo t II/4UU4/Uf241 -3 group consisting of bacteriocins, antimicrobial enzymes, sugars, sugar alcohols, iron binding proteins and derivatives thereof, siderophores, and combinations thereof In one aspect, the present invention provides an antimicrobial composition that includes: an antimicrobial lipid component (preferably, a major amount of an 5 antimicrobial lipid component) that includes a compound selected from the group consisting of a (C7-C14)saturated fatty acid ester of a polyhydric alcohol, a (C8 C22)unsaturated fatty acid ester of a polyhydric alcohol, a (C7-C14)saturated fatty ether of a polyhydric alcohol, a (C8-C22)unsaturated fatty ether of a polyhydric alcohol, an ailcoxylated derivative thereof, and combinations thereof, wherein the 10 alkoxylated derivative has less than 5 moles of alkoxide per mole of polyhydric alcohol (preferably, the antimicrobial lipid component does not include a glycerol monoester); an enhancer component that includes a compound selected from the group consisting of bacteriocins, Antimicrobial enzymes, sugars, sugar alcohols, iron-binding proteins and derivatives thereof, siderophores, and combinations thereof; and optionally a surfactant. 15 In another aspect, the present invention provides an antimicrobial composition that includes: an antimicrobial lipid component that includes a compound selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof; with the proviso that the antimicrobial lipid component does not include a glycerol monoester; .0 and an enhancer component including a compound selected from the group consisting of mannose, xylose, mannitol, xylitol; and combinations thereof. In another aspect, the present invention provides an antimicrobial composition that includes: an antimicrobial lipid component that includes a compound selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a 25 polyhydric alcohol, ailcoxylated derivatives thereof, and combinations thereof; with the proviso that the antimicrobial lipid component does not include a glycerol monoester; and an enhancer component that includes a compound selected from the group consisting of bacteriocins, antimicrobial enzymes, sugars, sugar alcohols, iron-binding proteins and derivatives thereof, siderophores, and combinations thereof, wherein the 0 pH of the composition is no higher than 6. In another aspect, the compositions may optionally also contain a surfactant (i.e., one or more surfactants). The surfactants can be chosen based on the anticipated WO 2005/022998 PCT/US2004/029241 -4 use of the composition. Suitable surfactants include acyl lactylate salts, dioctyl sulfosuccinate salts, lauryl sulfate salts, dodecylbenzene sulfonate salts, and salts of (C8-C18)fatty acids. In a further aspect of the present invention, the compositions containing food 5 grade components preferably exhibit effective antimicrobial activity without detrimentally affecting the taste, texture, color, odor, or appearance of food and food products. This may be evaluated by using a blind taste test. For food that is normally cooked, such as hamburger, blind taste testing should be conducted on the cooked food. The treated food is considered to have no effect on taste, texture, color, odor, or 10 appearance of food and food products, if there is no statistical difference between the treated product and a control untreated product. In another aspect, compositions containing components that are generally recognized as food grade (GRAS), such as many of the esters and enhancers of the present invention, preferably do not pose significant harmful toxicology or 15 environmental problems. Many of the compositions of the present invention can also be readily handled at a processing plant and are compatible with processing equipment. In another aspect, the present invention also includes a process of disinfecting foods or other surfaces. The method includes contacting the food or surface with a composition of the present invention. For certain embodiments, the composition is t0 concentrated and the method includes diluting the composition before application to a substrate. In certain embodiments, a method is provided that includes applying an antimicrobial lipid component, and applying an enhancer component, in one or more parts. When two or more parts are applied, for example, the enhancer component can be applied before or after the antimicrobial lipid component. 25 In one embodiment, the present invention provides a method of applying an antimicrobial composition to a substrate. The method includes applying to the substrate a major amount of an antimicrobial lipid component including a compound selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations 30 thereof; and applying to the substrate an enhancer component including a compound selected from the group consisting of bacteriocins, antimicrobial enzymes, sugars, sugar alcohols, iron-binding proteins and derivatives thereof, siderophores, and -5 combinations thereof The enhancer component can be applied simultaneously with, before, or after the antimicrobial lipid component. In another aspect of the invention, preferably at least a one-log average reduction of total aerobic bacteria count (i.e., many of which can cause food to spoil) 5 can be achieved on substrates (e.g., food products) using the formulations and me-thods disclosed herein. This can be determined according to the method described in Examples 5-7 using a sample of ground beef having an initial native bacteria concentration-of 10000 -100,000 bacteria/gram ground beef when sufficient composition is applied such that 1% antimicrobial lipid is applied to ground beef. More 10 preferably the compositions of this invention achieve at least 2 log average reduction, and even more preferably at least 3 log average reduction. Most preferably, compositions of the present invention achieve complete eradication of the native bacteria (such that the bacterial level is non-detectable). In particular formulations, the compositions are not inactivated by organic .5 matter. That is, compositions of the present invention are active in the presence of blood, serum, fats, and other organic matter typically found on food, and known to inactivate other antimicrobials such as iodine and quats. In another aspect, the invention features a ready-to-use antimicrobial formulation that includes a major amount of a propylene glycol fatty acid ester that 0 contains at least 60% fatty acid monoester, a minor amount of an enhancer, and optionally a surfactant, wherein the concentration of the propylene glycol fatty acid ester is greater than 30 percent by weight (wt-%) of the ready-to-use formulation and the concentration of the enhancer is 0.1 wt-% to 30 wt-% of the ready-to-use formula ation. 5 In yet another aspect, the invention features a kit that includes a first container that includes an antimicrobial lipid component including a compound selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof (preferably, the first container includes a major amount of a (C7-C14) propylene glycol fatty acid ester), and a second container that includes an enhancer component including a compound selected from the group consisting of bacteriocins, antimicrobial enzymes, WU 2005/U22998 PCT/US2004/029241 -6 sugars, sugar alcohols, iron-binding proteins and derivatvies thereof, siderophores, and combinations thereof In an alternate embodiment, the kit includes a first container having a composition with a major amount of a (C7-C14)propylene glycol fatty acid ester and an 5 enhancer, and a second container having a second enhancer. One or both containers in the kit may alsb optionally contain a surfactant. The kit further can include a label or package insert indicating that contents of the first container and the second container are preferably mixed to produce an antimicrobial formulation that is effective for reducing microbial contamination. The label or package insert further can indicate that 10 the antimicrobial formulation can be diluted before application to food, food products, or inanimate surfaces. Definitions "Major amount" means a component present in a concentration higher than any 15 other individual component. "Enhancer" means a component that enhances the effectiveness of the antimicrobial lipid such that when either the composition without the antimicrobial lipid or the composition without the enhancer component are used separately, they do not provide the same level of antimicrobial activity as the composition as a whole. For 20 example, an enhancer in the absence of the antimicrobial lipid may not provide any appreciable antimicrobial activity. The enhancing effect can be with respect to the level of ill, the speed of kill, and/or the spectnun of microorganisms killed; and may not be seen for all microorganisms. In fact, an enhanced level of kill is most often seen in Gram negative bacteria -such as Escherichia coli. An enhancer may be a.synergist 25 that when combined with the remainder of the composition causes the composition as a whole to display an activity greater than the sum of the activity of the composition without the enhancer component and the composition without the antimicrobial lipid. "Microorganism" or "microbe" refers to bacteria, yeast, mold, fungi, mycoplasma, as well as viruses. 30 "Shelf-Life" means a period of time it takes for a processed food to spoil. For example, beef can be considered to be spoiled if the bacterial count for an area of skin YVt kUUvv.n/Umk7zoa iiu 1/UUUL241 -7 (one square centimeter) is equal to or greater than 10'7 (colony fonning units per square centimeter). "Vehicle" means a carrier for the components of a composition. In antimicrobial compositions, the vehicle is typically the component-present in a major 5 amount. Antimicrobial "activity" includes activity against microbes, including but not limited to, gram-negative bacteria and gram-positive bacteria, fungi, fungal spores, yeast, mycoplasma organisms, and lipid-coaied viruses. The terms "comprises" and variations thereof do not have a limiting meaning 10 where these terms appear in the description and claims. As used herein, "a," "an," "the," "at least one," and "one or more" are used interchangeably. Also herein, the recitations of numerical ranges by endpoints include all numbers subsumed within that range-(e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, 5, 15 etc.). The above summary of the present invention is not intended to describe each disclosed embodiment or every implementation of the present invention. The description that follows more particularly exemplifies illustrative embodiments. In several places throughout the application, guidance is provided through lists of 20 examples, which examples can be used in various combinations. In each instance, the recited list serves only as a representative group and should not be interpreted as an exclusive list. Other features and advantages of the invention will be apparent from the following detailed description, and from the claims. DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS 25 The present invention comprises antimicrobial compositions (some of which are in concentrated form), and methods of use of these compositions. In one embodiment, a concentrated antimicrobial composition includes an antimicrobial lipid component including one or more compounds selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a 30 polyhydric alcohol, alkoxylated derivatives thereof (of either the ester or ether), and combinations thereof. The compositions further include an enhancer component including one or more compounds selected from the group consisting of bacteriocins, TV v atu-n .77o rUT/ UUU2UU4/U29241 -8 antimicrobial enzymes, sugars, sugar alcohols, iron-binding proteins and derivatives thereof, siderophores, and combinations thereof. The compositions of the present invention may further include other additives, including surfactants and flavorants and flavor masking agents. For those compositions 5 that include a major amount of the antimicrobial lipid that is liquid at room temperature, the antimicrobial lipid serves as both the active antimicrobial agent and a vehicle for the other components of the antimicrobial composition. The formulations can be used to treat a wide variety of substrates that are or may be contaminated by microorganisms. For example, the compositions can be used [0 to treat steel, glass, aluminum, wood, paper, polymeric materials, Formica, and other counter top surfaces, tile, ceramics, rubber, paper, and textiles such as cotton, nylon, polypropylene non-wovens, and linen. Other uses for the compositions, such as food and medical applications, are described in Applicants' Assignee's Co-pending Patent Application Serial Nos. 10/659,584 and 10/659,571, filed on September 9, 2003. Still .5 other uses for the compositions include dental applications. The antimicrobial lipid component includes one or more compounds selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof In . certain embodiments, the antimicrobial lipid component includes a compound selected o from the group consisting of a (C7-C14)saturated fatty acid ester of a polyhydric alcohol (preferably, (C8-C14)saturated fatty acid ester of a polyhydric alcohol), a (C8 C22)unsaturated fatty acid ester of a polyhydric alcohol (preferably, a (C 12 C22)unsaturated fatty acid ester of a polyhydric alcohol), a (C7-C14)saturated fatty ether of a polyhydric alcohol (preferably, a (C8-C1 4)saturated fatty ether of a 5 polyhydric alcohol), a (C8-C22)unsaturated fatty ether of a polyhydric alcohol (preferably, a (C1 2 -C22)unsaturated fatty ether of a polyhydric alcohol), an alkoxylated derivative thereof, and combinations thereof, wherein the ailcoxylated derivative has less than 5 moles of alcoxide per mole of polyhydric alcohol. Certain embodiments include a (C7-C14)fatty acid ester (preferably, (C8 0 C14)fatty acid ester), an unsaturated fatty acid ester of a polyhydric alcohol, a saturated fatty ether of a polyhydric alcohol, an unsaturated fatty ether of a polyhydric alcohol, an alkoxylated derivative thereof, and combinations thereof, wherein the allcoxylated ry vavvaaanorkI/UbZUU4/UZ9241 -9 derivative has less than 5 moles of alkoxide per mole of polyhydric alcohol. Particular embodiments include the known (C7-C14)fatty acid esters (preferably, (C8-C14)fatty ) acid esters), such as glycerol monoesters of lauric, caprylic and caprice acid and/or propylene glycol monoesters of lauric, and caprylic or capric acid. 5 Fatty acid esters are particularly useful candidates for treating food, and surfaces exposed to food, to reduce the number of human pathogens and spoilage in food since many of the monoesters have been reported to be food grade, generally recognized as food-grade (GRAS) materials, and have been reported to be effective as food preservatives and topical pharmaceutical agents. For example, Kabara, J. of Food [0 Protection, 44:633-647 (1981) and Kabara, J. of Food Safety, 4:13-25 (1982) report that LAURICIDIN (the glycerol monoester of lduric acid commonly referred to as monolaurin), a food grade phenolic and a chelating agent may be useful in designing food preservative systems. Fatty acid monoesters have been used for over 50 years as food grade emulsifying agents in foods such as pastry and bread dough, ice cream, 5 margarine, and salad dressings. Fatty acid monoesters, such as glycerol monoesters of lauric, caprylic capric, .and heptanoic acid and/or propylene glycol monoesters of lauric, caprylic, capric and heptanoic acid, are active against Gram positive bacteria, fungi, yeasts and lipid coated viruses but alone are not generally active against Gram negative bacteria. When the 0 fatty acid monoesters are combined with the enhancers in the composition, the composition is active against Gram negative bacteria, In particular, formulations of the invention can reduce the number of food-borne human pathogens in meat. For example, they can be used as sprays and dips to treat meat carcasses such as beef, pork, poultry, fish, and lamb carcasses. They can also be 5 used as sprays and dips to treat further processed meat such as ground beef, ground pork, ground chicken, ground turkey, hot dogs, sausages and lunch meats. Human food-bome pathogens killed by the formulations disclosed include, for example, B. coli 0157:H7, Listeria monocytogenes, and Salmonella serovars. Not only can the formulations of the present invention be used to remove 0 human pathogens from meat and meat products, they can also be used to help protect other foods, such as plants and plant parts, from human pathogens and other pathogens -10 that produce spoilage and adversely effect the quality and shelf life of fruits and vegetables. Generally, the components in the composition, as a whole, provide antimicrobial (including antiviral, antibacterial, or antifungal) activity having a 5 spectrum of sufficient breadth to kill, or reduce the number to an acceptable level of essentially most pathogenic or undesired bacteria, fungi, yeasts and lipid coated viruses. It should be understood that in the compositions of the present invention, the concentrations or amounts of the components, when considered separately, may not kill to an acceptable level, or may not kill as broad a spectrum of undesired microoiganisms, or may not kill as fast; however, when used together such components provide an enhanced (preferably synergistic) antimicrobial activity (as compared to the same components. used alone under the same conditions), Those of ordinary skill in the art will readily determine when a composition of the present invention provides enhanced or synergistic antimicrobial activity using assay and bacterial screening methods well known in the art. One readily performed assay involves exposing selected known or readily available viable bacterial strains, such as Escherichia colt, Staphylococcus spp., Streptococcus spp., Pseudom2onas spp. or Salmonella spp., to a test composition at a predetermined bacterial burden level in a culture media at an appropriate temperature. After a sufficient contact time, an aliquot of a sample containing the exposed bactera is collected, diluted, neutralized, and plated out ,on a culture medium such as agar. The plated sample of bacteria is incubated for about forty-eight hours and the number of viable bacterial colonies growing on the plate is counted. Once colonies have been counted, the reduction in the number of bacteria caused by the test composition is readily determined. Bacterial reduction is generally reported as logio reduction determined by the difference between the logo of the initial inoculum count and the log 0 of the inoculum count after exposure. Preferably, compositions of the invention demonstrate at least a one-log average reduction of total aerobic bacteria count when used on a substrate. To differentiate between enhanced activity and synergistic activity a checkerboard assay can be performed. Preferred compositions of the present invention may be physically stable. As defined herein "physically stable" compositions are those that do not significantly TV sun z MUE/UUZU4/029241 -11 change due to substantial precipitation, crystallization, phase separation, and the like, from their original condition during storage at 23*C for at least 3 months, and preferably for at least 6 months. Particularly preferred compositions are physically stable if a 10-milliliter (10-mi) sample of the composition when placed in a 15-mi 5 conical-shaped graduated plastic centrifuge tube (Corning) and centrifuged at 3,000 revolutions per minute (rpm) for 10 minutes using a Labofuge B, model 2650 manufactured by Heraens Sepatech OmbH, Osterode, West Germany (2275 x g) has no visible phase separation in the bottom or top of the tube. Preferred compositions of the present invention may exhibit good chemical 10 stability. This can be especially a concern with the antimicrobial fatty acid esters, which can often undergo transesterification, for example. Preferred compositions retain at least 85%, more preferably at least 90%, even more preferably at least 92%, and even more preferably at least 95%, of the antimicrobial lipid component after aging for 4 . weeks at 50"C (an average of three samples). The most preferred compositions retain 15 an average of at least 97% of the antimicrobial lipid after aging for 4 weeks at 50*C in a sealed container. The percent retention is understood to mean the amount of antimicrobial lipid component retained comparing the amount remaining in a sample aged in a sealed container that does not cause degradation to an identically prepared sample (preferably 20 from the same batch) to the actual measured level in a sample prepared and allowed to sit at room temperature for one to five days. For compositions that are meant to be in multiple parts, the part comprising the antimicrobial fatty acid ester preferably exhibits the above stability. 25 Antimicrobial Formulations Antimicrobial formulations of the invention may include one or more fatty acid esters, fatty ethers, or alkoxylated derivatives thereof, one or more enhancers, and optionally one or more surfactants. The compositions can be used for reducing levels of microorganisms, including gram-negative and gram-positive bacteria, viruses, fungi 30 and fungi spores on plants and plant parts, meat and other foods as well as on inanimate surfaces. As used herein, "reducing levels of microorganisms" includes inhibiting microbial growth, promoting microbial death, and removing microorganisms from the ". I " U .[/UMLUUJUly 24] -12 surfaces of plants or plant parts, meat and other foods as well as from inanimate surfaces. Preferred formulations of the present invention have a pH of no higher than .6, and more preferably, they have a pH of 4.5-5.5, when the composition is mixed in 5 water at the concentration suitable for application to food. Antimicrobial Lipids The antimicrobial lipid is that component of the composition that provides at least part of the antimicrobial activity. That is, the antimicrobial lipid has at least some 10 antimicrobial activity for at least one microorganism. It is generally considered the main active component of the compositions of the present invention. The antimicrobial lipid may include one or more fatty acid esters of a polyhydric alcohol, fatty ethers of a polyhydric alcohol, or alkoxylated derivatives thereof (of either or both of the ester and ether), or combinations thereof More specifically, the antimicrobial component can 15 include one or more compounds selected from the group consisting of a (C7 C14)saturated fatty acid ester of a polyhydric alcohol (preferably, a (C8-C 14)saturated fatty acid ester of a polyhydric alcohol), a (C8-C22)unsaturated fatty acid ester of a polyhydric alcohol (preferably, a (C1 2 -C22)unsaturated fatty acid ester of a polyhydric alcohol), a (C7-C14)saturated fatty ether of a polyhydric alcohol (preferably, a (C8 20 C14)saturated fatty ether of a polyhydric alcohol), a (C8-C22)unsaturated fatty monoether of a polyhydric alcohol (preferably, a (C12-C22)unsaturated fatty monoether of a polyhydric alcohol), an alkoxylated derivative thereof, and combinations thereof. A fatty acid ester of a polyhydric alcohol is preferably of the formula (R -C(O) 25 O)U-R 2 , wherein R' is the residue of a (C7-C14)saturated fatty acid (preferably, a (C8 C14)saturated fatty acid), or a (C8-C22)unsaturated (preferably, a (C12
C
2 2)unsaturated, including polyunsaturated) fatty acid, R2 is the residue of a polyhydric alcohol (typically glycerin, propylene glycol, or sucrose), and n = 1 or 2. The R2 group includes at least one free hydroxyl group (preferably, residues of 30 glycerin, propylene glycol, or sucrose). Preferred fatty acid esters of polyhydric alcohols are esters derived from C7, C8, C9, C10, C11, and C12 saturated fatty acids.
-13 For embodiments in which the polyhydric alcohol is glycerin or propylene glycol, n 1, although when it is sucrose, n = I or 2. Exemplary fatty acid monoesters include, but axe not limited to, glycerol monoesters of lauric (monolaurin), caprylic (monocaprylin), and capric (rnonocaprin) acid, 6nd propylene glycol monoesters of la-uric, caprylic, and capric acid, as well as lauric, caprylic, and capric acid monoesters of sucrose. Exemplary fatty acid diesters include, but are not limited to, lauric, caprylic, and capric diesters of sucrose. Other fatty acid monoesters include glycerin and propylene glycol monoesters of oleic (18:1), linoleic (18:2), linolenic (18:3), and arachidonic (20:4) unsaturated (including polyunsaturated) fatty acids. As is generally know, 18:1, for example, means the compound has 18 carbon atoms and 1 carbon-carbon double bond. In certain preferred embodiments, and in particular those embodiments for use with food products, the fatty acid monoesters that are suitable for use in the present composition would include known monoesters of lauric, caprylic, and capric acid, such as GML or the trade designation LAURICIDIN (the glycerol monoester of lauric acid commonly referred to as monolaurhi or glycerol monolaurate), glycerol monocaprate, glycerol monocaprylate, propylene glycol nionolaurate, propylene glycol monocaprate, propylene glycol monocaprylate, and combinations thereof A fatty ether of a polyhydric alcohol is preferably of the formula (R 3
-O),-R
4 , wherein R3 is a (C7-C12)saturated aliphatic group (preferably, a (C8-Cl2)saturated aliphatic group), or a (C8-C22)unsaturated (preferably, a (C12-C22)unsaturated, including polyunsaturated) aliphatic group; R 4 is the residue of glycerin, sucrose, or propylene glycol, and n = I or 2. For glycerin and propylene glycol n =1, and for sucrose n = I or 2. Preferred fatty ethers are monoethers of (C7-C12)alkyl groups (preferably, (C8-C12)alkyl groups). Exemplary fatty monoethers would include, but are not limited to, laurylglyceryl ether, caprylglycerylether, caprylylglyceryl ether, laurylpropylene glycol ether, caprylpropyleneglycol ether, and caprylylpropyleneglycol ether. Other fatty . monoethers include glycerin and propylene glycol monoethers of oleyl (18:1) linoleyl (18:2), linolenyl (18:3), and arachonyl (20:4) unsaturated and polyunsaturated fatty alcohols. Fatty mono ethers that are suitable for use in the present composition include laurylglyceryl ether, caprylglycerylether, caprylyl glyceryl ether, laurylpropylene f. hU lIUhh/YY- FL. I/0329UU4/U4Y241 -14 glycol ether, caprylpropyleneglycol ether, caprylylpropyleneglycol ether, and combinations thereof The ailcoxylated derivatives of the aforementioned fatty acid esters and fatty ethers (e.g., one which is ethoxylated and/or propoxylated on the remaining alcohol 5 group(s)) also have antimicrobial activity as long as the total alkoxylate is kept relatively low. Preferred alkoxylation levels are disclosed in U.S. Pat. No. 5,208,257 (Kabara). In the case where the esters and ethers are ethoxylated, the total moles of ethylene oxide is preferably less than 5, and more preferably less than 3. The fatty acid esters or fatty ethers of polyhydric alcohols can be alkoxylated, 10 preferably ethoxylated and/or propoxylated, by conventional techniques. Alkoxylating compounds are preferably selected from the group consisting of ethylene oxide, propylene oxide, and mixtures thereof, and similar oxirane compounds. The compositions of the present invention may include one or more fatty acid esters, fatty ethers, allcoxylated fatty acid esters, or alkoxylated fatty ethers at a suitable 15 level to produce the desired result. When diluted with a vehicle, the antimicrobial compositions can include a total amount of such material of at least 0.01 percent by weight (wt-%), preferably at least 0.10%, and more preferably at least I wt-%, based on the total weight of the composition. Preferred compositions of the present invention that include one or more fatty 20 acid monoesters, fatty mono ethers, or alkoxylated derivatives thereof can also include a small amount of a di- or tri-fatty acid ester (i.e., a fatty acid di- or tri-ester), a di- or tri fatty ether (i.e., a'fatty di- or tri-ether), or alkoxylated derivative thereof. For monoesters, monoethers, or alkoxylated derivatives of propylene glycol, preferably there is no more than 40% of the di- functional material. For monoesters, monoethers, 25 or alkoxylated derivatives of glycerin, preferably there is only a small amount of the di or tri- functional material. In the case of fatty acid monoesters and fatty monoethers of glycerin, preferably there is no more than 15 wt-%, more preferably no more than 10 wt-%, even more preferably no more than 7 wt-%, even more preferably no more than 6 wt-%, and even more preferably no more than 5 wt-% of a diester, diether, triester, 30 triether, or alkoxylated derivatives thereof present, based on the total weight of the antimicrobial lipid present in the composition. As used herein, "fatty" refers to a -15 straight or branched chain alkyl or alkylene moiety having 6 to 14 (odd or even number) carbon atoms, unless otherwise specified. When propylene glycol fatty acid esters are used, these esters in the composition can serve a dual purpose as both the antimicrobial active and the vehicle without the need of another aqueous or non-aqueous solvent as a separate vehicle. Other antimicrobial lipids that are liquid at or above 4 0 C can also serve as both the vehicle and the antimicrobial active. These concentrated compositions may both increase efficacy and at the same time give stable compositions and reduce costs of use. In certain embodiments, the antimicrobial lipid component includes a (C7 to C14)fatty acid ester (preferably, a (C8 to C14)fatty acid ester). In certain embodiments, the antimicrobial lipid component includes a fatty ether of a polyhydric alcohol, alcoxylated derivatives thereof, or combinations thereof In certain embodiments, the antimicrobial lipid component does not include a glycerol monoester, In certain embodiments, the antimicrobial lipid component includes a compound selected from the group consisting of a (C7-C14)fatty acid ester (preferably, a (CS-C14)fatty acid ester), an unsaturated fatty acid ester of a polyhydric alcohol, a saturated fatty ether of a polyhydric alcohol, an unsaturated fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof, wherein the - alkoxylated derivative has less than 5 molesof alkoxide per mole of polyhydric alcohol. Enhancers Compositions of the present invention include an enhancer (preferably a synergist) to enhance the antimicrobial activity. The enhancers may be selected from the group consisting of bacteriocins, antimicrobial enzymes, iron-binding proteins and derivatives thereof, siderophores, sugars, sugar alcohols, and combinations thereof The preferred enhancers are selected from the following classes of compounds discussed below. Suitable bacteriocins can include those produced by lactic acid producing bacteria used in food production, including genera Lactobacillus, Lactococcus, Leucormostoc and Pediococcus Bacteriocins may also be found in C. Nettles and S.
-16 Barefoot, Journal of Food Protection, Yol 56, No. 4, April 1993, pps. 338-356 Examples from such bacteriocins include, but are not limited to, nisin and Pediocin AcH. Other examples of bacteriocins are produced by gram-positive bacteria including Staphylococcins and others listed in Bacteriological Reviews, Sep 1976, pp. 722-756. 5 Bacteriocins produced by gram-negative bacteria, such as those produced by Enterocins A and B, Colistin (Polymyxin E), Colicin E1, and Polynyxin B bacteria, may also be used as enhancer. Suitable antimiibrobial enzymes produced by bacteria may include lysostaphin and lysozyme, as well as genetically altered or recombinant forms ofthese enzymes, 3 which may differ from the native protein in primary amino acid sequence. Examples of recombinant forms of lysostaphin may be found in U.S. Patent Application Publication No. 2002/0006406 (lysostaphin analogs) and U.S. Patent Application Publication No. 2003/0215436Al (lysostaphin polymer conjugates). Iron-binding compounds include both small siderophores and iron-binding proteins and derivatives thereof Suitable iron-binding siderophores include organic molecules having a molecular weight of less than 1000 daltons (typically, 400-1000 daltons) that are released by bacteria in iron-limiting situations to complex ferric ion and prevent precipitation of iron oxyhydroxides in the natural environment. They are composed of hydroxamate and phenolate derivatives, Which provide high affinity complexation sites for ferric ion. Examples of such molecules are high affinity ferric ion chelators synthesized by bacteria, which may include, but are not limited to, enterochelin (enterobactin), vibriobactin, Anguibactin, pyochelin, Pyoverdin, Mycobactin, Exochelins, Aerob actin, and D esferi ox amine. Suitable iron-binding proteins include lactoferrin and derivatives thereof, particularly peptides derived therefrom (e.g., lactoferricin B, lactoferricin H, derived by enzymatic cleavage of lactoferrin and activin) and transferrin. In certain embodiments, lactoferrin is a preferred enhancer. Suitable sugars can include bo-th monosaccharides and disaccharides. Suitable monosaccharides include, but are not limited to, mannose, xylose, maltose, sorbose, and their corresponding sugar alcohols mannitol, xylitol, maltitol, and sorbitol. In certain preferred embodiments, the sugar is selected from the group consisting of -17 mannose, xylose, mannitol,.xylitol, and combinations thereof In certain embodiments, the sugar is a disaccharide of xylitol and glucose. For disaccharides, at least one of the sugars is preferably one of the suitable monosaccharides listed herein. The second sugar unit may be selected from any suitable sugar commonly used in food products, such as but not limited to, glucose, fructose, mannose, xylose; galactose, sorbose, and sorbitol. It should be understood that various combinations of enhancers can be used if desired. In some embodiments, significant results can be obtained through the use of a combination of enhancers. Certain compositions of the present invention include at least two enhancers, and preferably at least three enhancers, of different classes of compounds. For example, certain embodiments include an enhancer selected from the group consisting of iron binding proteins, siderophores, and combinations thereof with at least one other enhancer of at least one different class of compound. Alternatively, certain embodiments include an enhancer selected from the group consisting of iron binding proteins, siderophores, and combinations thereof with at least two other enhancers of at least two different classes of compound. Such other enhancers can be selected from the group consisting of bacteriocins, aitimicrobial enzymes, sugars, sugar alcohols, and combinations thereof In one embodiment, the enhancer component includes nisin and lactoferin. In one embodiment, the enhancer component comprises nisin, lactoferrin, and a sugar and/or a sugar alcohol. Compositions that include nisin, particularly in combination with various non bactericidal agents, have been shown to be highly active against various species of Gram-positive and Gram-negative bacteria (see, e.g., U.S. Pat. Nos. 5,135,910; 5,217,950, and 5,260,271). More recently, bactericidal activity of nisin, in the presence of chelators, has been described against additional Gram-negative bacteria, including -elicobacterpylori (see, e g., U.S. Pat. Nos. 5,304,540 and 5,334,582). Glycerol monolaurate and nisin, which alone are suboptimal in their bactericidal effect, mutually enhance the bactericidal activity of one another in combination against strains of the genus Helicobacter. The formulations of nisin with glycerol monolaurate, however, can be ineffective as. antimicrobial compositions applied to meat and other food products. In certain preferred embodiments, nisin is not included.
-18 Other classes of enhancer compounds, such as an organic acid, a cheating agent, a phenolic compound, or an alcohol (as described in Applicants' Copending Application, Publication No. US 2005-0089539-Al, filed same date herewith), may also be added to the antimicrobial compositions. Suitable organic acids can include, for example, lactic acid, tartaric acid, adipic acid, succinic acid, citric acid, ascorbic acid, glycolic acid, malic acid, mandelic acid, acetic acid, sorbic acid, benzoic acid, and salicylic acid. In certain embodiments, tie enhancer component includes an organic acid and a compound selected from the group consisting of bacteriocins, antimicrobial enzymes, sugars, sugar alcohols, iron-binding proteins and derivatives thereof, siderophores, and combinations thereof In one embodiment, the enhancer component includes an organic acid, lactoferrin, and either a sugar, a sugar alcohol, or both. Suitable chelating agents can include, for example, sodium acid pyrophosphate acidic sodium hexametaphosphate (such as SPORIX acidic sodium hexametaphosphate), ethylenediamninetetraacetic acid (EDTA) and salts thereof. Suitable alcohols can be, for example, ethanol, isopropanol, or long chain alcohols such as octanol or decyl alcohol. Phenolic compounds such as butylated hydroxyanisole, butylated hydroxytoluene, and tertiary butyl hydroquinone, for example, enhance the activity of the fatty acid monoesters as do benzoic acid derivatives such as methyl, ethyl, propyl, and butyl parabens. Other suitable enhancers include those listed in Applicants' Assignee's Co-pending Patent Application Serial No. 10/659,584, filed on September 9, 2003. In certain preferred embodiments, the organic acid enhancer is benzoic acid and the phenolic compound enhancer is methyl paraben (4 hydroxybenzoic acid methyl ester). Surfactants Compositions of the present invention may include a surfactant to emulsify the composition and to help wet the surface to aid in contacting the microorganisms. As used herein the term "surfactant" means an amphiphile which is defined as a molecule possessing both polar and nonpolar regions which are convalently bound. The term is meant to include soaps, detergents, emulsifiers, surface active agents and the like. The surfactant can be cationic, anionic, nonionic, or zwitterionic. This includes a wide VVtP UIU O EUmu4me FUT/U 2414/029241 -19 variety of conventional surfactants; however, certain ethoxylated surfactants may reduce or eliminate the antimicrobial efficacy of the antimicrobial lipid. The exact mechanism of this is not known and not all ethoxylated surfactants display this negative effect. For example, poloxamer polyethylene oxide/polypropylene oxide surfactants 5 have been shown to be compatible with the antimicrobial lipid component, but ethoxylated sorbitan fatty acid esters such as those sold under the trade name TWEEN by ICI have not been compatible in some formulations. It should be noted that these are broad generalizations and the activity can be formulation dependent, i.e., based on the selection and amount of both antimicrobial lipid and ethoxylated surfactant used. 10 One skilled in the art can easily determine compatibility of a surfactant by making the formulation and testing for antimicrobial activity as described. in the Examples Section. Combinations of various surfactants can be used if desired. Anionic surfactants, cationic surfactants, nonionic surfactants and amphoteric surfactants may be used to make suitable emulsions of the antimicrobial fatty acid 15 esters. For example, an antimicrobial formulation can include anionic surfactants such as acyl lactylate salts, dioctyl sulfosuccinate salts, lauryl sulfate salts, dodecylbenzene sulfonate salts, and salts of (C8-Cl8)fatty acids. Suitable salts include sodium, potassium, or ammonium salts. Acyl lactylates include, for-example, calcium or sodium stearoyl-2-lactylate, sodium isostearoyl-2-lactylate, sodium lauroyl-2-lactylate, 0 sodium caproyl lactylate, sodium cocoyl lactylate, and sodium behenoyl lactylate. Nonionic surfactants include glycerol esters such as decaglyceryl tetraoleate; sorbitan esters such as sorbitan monolaurate, commercially available under the trade designation SPAN 20 from Uniquema International, Chicago, IL; and block copolymers of polyalkylene oxide, eg., polyethylene oxide and polypropylene oxide available under 25 the trade designations PLURONIC and TETRONIC from BASF (Parsippany, NJ). Dioctyl sodium sulfosuccinate is commercially available under the trade designation GEMTEX SC40 surfactant (40% dioctyl sodium sulfosuccinate in isopropanol) from Finetex Inc., Spencer, North Carolina. Sodium caproyl lactylate is commercially available under the trade designation PATIONIC 122A from RITA (Woodstock, IL). 0 Sodium lauryl sulfate is commercially available from Stepan Chemical Co., Northfield,
IL.
vv u LuI..Y0 FUT/U52U4/029241 -20 Other surfactants that may be suitable for use in the antimicrobial compositions of the present invention are listed in Applicants' Assignee's Co-pending Patent Application Serial No. 10/659,584, filed on September 9, 2003. 5 Applications with Food The formulations of the invention are particularly useful for reducing levels of food borne human pathogens, including Escherichia coli 0157:H7, Salmonella serotypes, including S. typhimurium, Listeria (e.g., L. monocytogenes), Campylobacter (e.g., C jejuni), Shigella species, and Bacillus cereus. 10 Fatty acid monoesters suitable for use in the antimicrobial formulations generally are considered food grade, GRAS, and/or are U.S. Food and Drug Administration (FDA)-cleared food additives. In particular, one or more fatty acid monoesters derived from C7 to C12 fatty acids (preferably, C8 to C12 fatty acids) such as glycerol monoesters of caprylic, capric, or lauric acid and/or propylene glycol .5 monoesters of caprylic, capric, or lauric acid may be useful in formulations of the invention. Combinations of fatty acid monoesters can be tailored to the target microorganism. For example, laurate monoesters can be combined with caprylate monoesters and/or caprate monoesters when it is desired to reduce levels of fungi on the surface of a plant or plant part. o Monoglycerides useful in the invention typically are available in the. form of mixtures of unreacted glycerol, monoglycerides, diglycerides, and triglycerides. Thus, it is preferred to use materials that contain a high concentration, e.g., greater than 60 wt-% of monoglyceride. In some compositions, the desired materials will contain concentrations greater than 85 wt-% or 90 wt-% of monoglyceride. Examples of 5 particularly useful commercially available materials include glycerol monolaurate (GML), available from Med-Chem Laboratories, East Lansing, MI, under the tradename LAURICIDIN, glycerol monocaprylate (GM-C8) and glycerol monocaprate (GM-C 10) available from Riken Vitamin Lid., Tokyo, Japan under the tradenames POEM M-100 and POEM M-200, respectively, and those available from the Henkel 0 Corp. of Germany under the tradename "MONOMULS 90 L-12". Propylene glycol monocaprylate (PG-C8), propylene glycol monocaprate (PG-C 10), and propylene glycol monolaurate (PG-C12) are available from Uniquema International, Chicago,
IL.
TV JEi Io ILUU4/U29241 -21 In food applications, the enhancers are food grade, GRAS listed, and/or FDA cleared food additives. The amounts of enhancer in the present invention may be up to 20.0 wt-%, and preferably 1.0 wt-% to 10.0 wt-%. In other embodiments, such as those that include a vehicle, the enhancer may include 0,01 wt-% to 1.0 wt-%, and preferably. 5 0.01 wt-% to 0.5 wt-%. Lower concentrations of enhancer may be necessary, in part, in order to avoid undesired changes or alterations to the taste, texture, color, odor or appearance of the food. Depending on the particular enhancer used, it can eitlier be formulated directly into the concentrate vehicle if soluble and stable in the esters or it can be packaged-separately in a suitable solvent. 10 In most compositions, food grade and/or GRAS surfactants may be used in amounts which provide a concentrated composition of 1.0 wt-% to 30.0 wt-%, and preferably 4.0 wt-% to 12. 0 wt-%. In other embodiments that include a vehicle, the composition may provide a surfactant concentration of 0.001 wt-% to 1.0 wt-%, and preferably 0.01 wt-% to 0.5 wt-%. 5 The concentration of the aforementioned components required for effectively inhibiting microbial growth depends on the type of microorganism targeted and the fonnulation used (e.g., the type of antimicrobial lipid, enhancer, and surfactants that are present). The concentrations or amounts of each of the components, when considered separately, may not kill as great a spectrum of pathogenic or undesired microorganisms, 0 kill them as rapidly, or reduce the number of such microorganisms to an acceptable level, as the composition as a whole. Thus, the components of the formulation, when used together, provide an enhanced or synergistic antimicrobial activity to the meat, plants or plant parts, or other treated surfaces when compared to the same components used alone and under the same conditions. Acceptable levels of antimicrobial activity 5 typically exceed 1-log reduction in or on a food, or other surface. Effective amounts of each component can be readily ascertained by one of skill in the art using the teachings herein and assays known in the art. The compositions of the invention may be prepared and used directly or can be diluted to prepare a non aqueous or aqueous solution, emulsion or suspension before use. Suitable vehicles for 3 preparing the solutions or suspensions are typically acceptable to regulatory agencies such as the FDA and the U.S. Environmental Protection Agency (EPA). Particularly acceptable vehicles include water, propylene glycol, polyethylene glycol, glycerin, "-rt I / U4UU4/U2Y441 -22 ethanol, isopropanol, and combinations thereof Alternatively, one or more antimicrobial lipids may function as the vehicle. In preferred embodiments, the fatty acid monoglyceride is 0.001 wt-% to 30 wt %, the enhancer is 0.001 wt-% to 30 wt-%, and one or more surfactants are 0.001 wt-% 5 to 30 wt-% of the antimicrobial formulation. For example, a ready-to-use formulation can include 0.01 wt-% to 5.0 wt-% of a fatty acid monoester, 0.5 wt-% to 30 wt-% of an enhancer, and 0.5 wt-% to 5.0 wt-% of a surfactant. In particular, a ready-to-use formulation can include 0.2 wt-% to 2.0 wt-% of the fatty acid monoester, 0.1 wt-% to 25.0 wt-% of the enhancer, and 0.1 wt-% to 1.5 wt-% of one or more surfactants. 10 Additional components of the antimicrobial formulations can include, for example, food-grade coating agents such as beeswax, paraffin, carnauba, candelilla and polyethylene waxes; other coating materials including resins, shellac, wood rosin, corn zein; and components that protect the formulations from UV inactivation or degradation, colorants, odor-enhanbing agents, viscosity control agents such as gum 15 tragacanth, gum accacia, carageenans, Carbopols (B.F. Goodrich, Cleveland, Ohio), guar gum, and cellulose gums; anti-foaming agents such as silicone anti-foams, e.g., polydimethylsiloxanes (Dow Corning, Midland, MI), sticking agents, or flavorants such as natural oils or artificial sweeteners. Antimicrobial formulations used in food applications typically exhibit increased 20 antimicrobial efficacy with increased temperatures at application. Treating Meat and Meat Products The composition of the present invention may be prepared by combining the above described components using processes and procedures well known to those of 25 ordinary skill in the art. For example, a concentrated composition is prepared by heating a propylene glycol fatty acid ester to 70"C, adding a surfactant, and then adding an enhancer soluble in the fatty acid ester to form a solution. In some embodiments, the antimicrobial lipid can be applied in a separate step from applying the enhancer. The compositions of the present invention may be used in a food processing 30 plant in a variety of suitable ways during various stages of the process. For example, the present composition may be applied to meat products, such as beef carcasses, beef trim, beef primals, or ground meat as a spray, a rinse, or a wash solution. The meat VI * ~WtU~tfl L ki UO-)SUU4/U1YZ4qI -23 products may also be dipped in the composition. In addition, the present invention has a wide useful temperature range which allows the composition to be used at different stages in a process plant. For example, the composition may be used at elevated temperatures to disinfect beef carcasses and at cold (4-5*C) temperatures to disinfect 5 ground beef and beef trim. The compositions of the present invention may also be useful in the products and processes disclosed in U.S. Patent Nos. 5,460,833 and 5,490,992. Treating Plants and Plant Parts 10 Using the formulations of the present invention, levels of plant pathogens may be reduced on the surfaces of plants and plant parts, which can extend shelf life of the plants and plant parts. Non-limiting examples of plant pathogens include Erwinia carotovora, Fusariun species, Botrytis species, Phytopthera species, Phoma species, Verticilium species, Penicillium species, and Colletotrichum species. The formulations 15 of the invention may also be effective at reducing viability of spores on surfaces of plants and plant parts, such as spores from penicillium fungi. Formulations of the invention can be applied to plants and plant parts by, for example, spraying, dipping, wiping, brushing, sponging, or padding. The formulation can be applied to a portion of or over the entire exterior surface of a plant or plant part. 20 In most applications, the entire surface of the plant or plant part is fully wetted with the fonnulation. In some embodiments, the antimicrobial lipid can be applied in a separate step from applying the enhancer. Formulations can be applied at temperatures ranging from 2*C to 90"C and are in contact with the surface of the plant or plant part for a time sufficient to reduce 25 microbial levels (e.g., 10 seconds to 60 minutes). Typically, application time is reduced as temperature is increased. Heating the formulation to between 40*C and 65"C (e.g., 44-60"C, 46-58*C, 48-56"C, or 50-54"C) and applying to the surface while still warm may be particularly effective for reducing microbial levels on plants or plant parts. Also, if the plant or plant part is cooked, compositions of the present invention 30 can be particularly effective. If present, the liquid vehicle can be removed from the surface of plant or plant part by, for example, air drying.
", 'v'' rL /t UZUU4/U29241 -24 Suitable plants and plant parts may include raw agricultural commodities (i.e., non-processed products) and processed products. Non-limiting examples of raw agricultural commodities include alfalfa seeds, sprouts, cucumbers, melons, onions, lettuce, cabbage, carrots, potatoes, eggplants, citrus fruits such as grapefruits, lemons, 5 limes, and oranges, bananas, pineapples, kiwis, and apples. Processed products include torn, sliced, chopped, shredded, or minced fruits or vegetables, as well as juice obtained from fruits or vegetables. For example, a fruit such as an orange can be treated with an antimicrobial formulation of the invention, air-dried, then coated with a food-grade wax. This 10 produces an orange having the antimicrobial formulation interposed between the orange and the food-grade coating. Alternatively, the antimicrobial formulation and a food grade coating can be intermixed prior to application. In another alternative, the food grade wax may be applied to fruit, such as an orange, and then the fruit can be treated with the antimicrobial composition over the wax. These may be conveniently applied 15 as an aqueous dispersion. Suitable waxes are beeswax, cetyl palmitate, and the like. The compositions of the present invention may also be useful in the products and processes disclosed in International Publication No. WO 200143 549A. They may also be useful in treating rood processing equipment, medical devices, cloth, paper, or any surface where a bactericidal activity is desired, 20 Dental Applications The present invention provides antimicrobial dental compositions and methods of using and making the compositions, Such compositions are useful for the treatment of oral diseases such as caries or periodontal disease caused by effective reduction, 25 prevention or elimination of the causative bacterial species. Typically the compositions are applied topically to the oral hard or soft tissues or are compositions that are used to restore the oral hard tissues. Oral hard tissues include dental structure surfaces that include tooth structures (e.g., enamel, dentin, and cementum) and bone. Oral soft tissues include mucosal tissues, i.e., mucous membranes. Such compositions can 30 provide effective reduction, prevention, or elimination of microbes, particularly bacteria, fungi, and viruses. In certain embodiments, the dental compositions of the present invention have a broad spectrum of activity.
- ra it U0hUVF4IUhYZ4I. -25 Certain dental compositions of the present invention provide effective topical antimicrobial activity and are accordingly useful in the local treatment and/or prevention of conditions that are caused or aggravated by microorganisms (including viruses, bacteria, fungi, mycoplasma, and protozoa) on oral tissue or dental materials. 5 Significantly, certain embodiments of the present invention have a very low potential for generating microbial resistance. Thus, such compositions can be applied multiple times over one or more days to treat oral surface infections or to eradicate unwanted bacteria. Furthermore, compositions of the present invention can be used for multiple treatment regimens on the same patient without the fear of generating antimicrobial 10 resistance. Dental compositions suitable for infection control of devices used in the mouth and then handled extraorally are also within the scope of this invention. Dental compositions of the present invention include one or more antimicrobial lipid component such as a fatty acid ester of a polyhydric alcohol, a fatty ether of 15 polyhydric alcohol, alkoxylated derivatives thereof etc. Fatty acid monoesters are preferred materials. Preferred fatty acid monoesters include glycerol monolaurate, glycerol monocaprate, glycerol monocaprylate, propylene glycol monolaurate, propylene glycol monocaprate, propylene glycol monocaprylate, and combinations thereof. -20 Certain preferred dental compositions contain an enhancer or synergist selected from the group consisting of organic acids (for example, benzoic acid), sugars (such as xylose and mannose), sugar alcohols (such as xylitol), bacteriocins (such as nisin), proteins (such as lactoferrin), and combinations thereof. Other components that can be included are surfactants (such as diocyl sodium sulfosuccinate), hydrophilic 25 components (such as a glycol, a lower alcohol ether, a short chain ester, and combinations thereof), and hydrophobic components. The compositions may be used in concentrated form or further combined in either an aqueous or nonaqueous vehicle before use. A further aspect of this invention is a dental composition for chemo-mechanical 30 or enzymatic removal of a carious lesionwhich effectively eliminates any residual caries bacteria in the affected zone. In some embodiments a separate antimicrobial -26 composition can be applied after removal of the carious lesion by the chemo mechanical, enzymatic or purely mechanical means. The antimicrobial compositions of the present invention may be used in the form of a spray, wash, rinse, liquid, paste, or powder to reduce the concentration of 5 deleterious bacteria, e.g., Streptococcus mutans, in the mouth. Such dental products include, but are not limited to, oral rinses (e.g., mouthwashes), oral irrigational solutions, demineralization solutions, and the like. In another aspect, the compositions can be used for oral prophylaxis, e.g., prophy pastes, prophy powder, sub-gingival cleansing, and the like. Compositions for use directly on a hard dental structure include 10 dentifrices (e.g., toothpastes), denture adhesives, and etchants. Compositions of the present invention may also be used to provide antimicrobial protection of dental articles as well as dental equipment, such as, for example, dental impression trays, dental instruments, dental floss, dental picks, dental tape, dental packing (e.g., fibers), and the like. 15 Articles of Manufacture Formulations of the invention can be packaged into kits. Some antimicrobial lipids can be inherently reactive, especially in the presence of enhancers. For example, the fatty acid monoesters can hydrolyze in an aqueous medium to the corresponding 20. fatty acid, transesterify with a hydroxy-containing enhancer (e.g., lactic acid), or transesterify with a hydroxy-containing solvent. Depending on the components chosen, the antimicrobial activity of the liquid composition may be reduced and shelf life may be shortened to less than one year. Thus, the formulations may be packaged conveniently in a two-part system (kit) 25 to increase stability. In one example of a two-part system, all components of the formulation, except the enhancer, are present in one container, while the enhancer is present in a separate container. In another example, the first container will contain all the components of the composition, including an enhancer soluble in the propylene glycol fatty acid ester, while the second container houses a second enhancer. Contents 30 from each container are mixed together and may be diluted before treating the applicable food or surface.
TV U LUU4/UL4'44j -27 In some embodiments, the antimicrobial formulation is packaged in a single container having separate compartments for storing various components,, e.g., the enhancer is in one compartment and the antimicrobial lipid, and optionally one or more surfactants, and a second enhancer are in a second compartment of the same container. 5 Such two-compartment containers typically'employ a breakable or displaceable partition between the two compartments. The partition then can be either broken or displaced to allow mixing. Alternatively, the container is configured such that a portion of the contents from each compartment can be removed, without mixing the entire contents of each compartment. See, for example, U.S. Patent Nos. 5,862,949, 10 6,045,254 and 6,089,389 for descriptions of two-compartment containers. Unless otherwise defined, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described herein can be used to practice the invention, suitable methods and materials 15 are described below. In case of conflict, the present specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting. The invention will be further described in the following examples, which do not limit the scope of the invention described in the claims. 20 EXAMPLES The following examples are intended to provide further details and embodiments related to the practice of the present invention. The following examples are offered for illustrative purposes to aid in understanding of the present invention and are not to be construed as limiting the scope thereof All materials are commercially 25 available unless otherwise stated or apparent. All parts, percentages, ratios, etc., in the examples are by weight unless otherwise indicated. GLOSSARY Nomenclature Material in the text Supplier Glycerol monolaurate GMLC12 Med-Chem. Labs, MI Propylene Glycol MonoCaprylate PGMC8 Unigema, NJ Sodium caproyl lactylate Pationic 122A RITA Chicago, IL ," t, vv nM L I Un4UU4/UL9Z41 -28 Sodium Lauroyl lactylate Pationic 138C RITA Chicago, IL Sorbitan Monolaurate Span 20 Uniqema, NJ 50% Dioctyl Sodium Cytec Industries/ West Sulfosuccinate DOSS ate rs/ Ws in PEG-400 Paterson, NJ Butylated Hydroxyanisole BHA EASTMAN, TN PLURONIC P65 Surfactant PLURONIC P65 BASF, NJ Benzoic Acid Mallinckrodt, St. Louis, Benzoic Acid MO Lactic Acid Lactic Acid PURAC, Lincoinshire, IL Xylitol Xylitol Sigma-Aldrich/ St. Louis, MO Xylose Xylose Avocado D-Mannose- D-Mannose Sigma-Aldrich/ St. Louis, MO Mannitol Mannitol Sigma-Aldrich/ St. Louis, MO Lactoferrin Lactoferrin DMV international, NY Transferrin Transferrin Sigma-Aldrich/ St. Louis, MO Nisin Nisin . Sigma-Aldrich/ St. Louis, (40,000 unit/mg) MO Colistin (Polymyxin E), Sulfate Colistin Sigma-Aldrich/ St. Louis, Salt, at leastl5,000 units/mg MO Examples 1-4 and Comnarative Examplies Cl-C8: Antimicrobial efficacy on hard surfaces Concentrate 1 was prepared by mixing 94 parts by weight of PGMC8 and 6 5 parts by weight DOSS. Example solutions were prepared by diluting Concentrate 1 to 0.5-1 wt-% in water with Mannitol or Lactoferrin or Nisin or Colistin, respectively, to prepare the example solutions. The proportions mixed are presented in Table 1 and Table 2 for the various enhancers. The solutions were shalcen until a milky emulsion formed. The emulsion solutions were used immediately after being made. The pH 10 values of all final solutions were in the range of 4.5-5. Comparative examples were prepared in the same manner with either the enhancer or the antimicrobial lipid not present.
rL 1/UbLUU4/IJ29241 -29 Table 1. Formulations for Examples1-3 and Comparative Examples Cl-C6. w/w% Comp. Comp. Comp. Comp. Comp. Comp. Table 1 Ex. Cl Ex. C2 Ex. C3 Ex. C4 Ex. C5 Ex. C6 Ex. 1 Ex. 2 Ex. 3 Formulation 2 3 4 5 6 7 8 9 10 Concentrate 1 1.0 0.9 1.0 0.9 0.9 Mannitol 15.0 15.0 Nisin 0.15 0.10 0.15 Lactoferrin 1.0 1.0 1.0 Water 99.0 99.5 98.9 99.0 99.1 85.0 98.0 98.9 84.1 pH 4.5-5 Table 2. Formulations for Example 4 and Comparative Examples C7 and C8 Comparative Comparative Table 2 Example 4 Example C7 Example CS Formulation Formulation Formulation 13 11 12 Concentrate 1 0.90 0.90 Colistin 0.050 0.050 Water 99.05 99.1 99.95 4.5-5 5 Inoculums and testing procedure: The procedure from AOAC Official Method (AOAC Official Method 991.49, 6.2.05), Testing guidance Disinfectants Against Pseudomonas aeruginosa, was used for testing disinfectant against Pseudomonas (ATCC 9027) and AOAC Official Method 955.15: Testing Disinfectants against Staphylococcus aureus was used for testing 10 disinfectants against the Methicilum Resistant Staphylococcus Aureus (MIRSA) (ATCC# 33593). Initial Inoculums: Pseudomonas: 8.00 logs(lx 10 colony-forming units (CFU) per milliliter (mL)); MRSA 8 log(lx 108 CFU/mL). In this test, hollow glass cylinders (penicylinders) were coated with the challenge bacteria. The bacteria were allowed to dry on the penicylinders for 1 hour 15 (hr). The penicylinders with the dried bacteria were dipped into the example formulation for 24 hours, removed, and placed into neutralizer solution (D/E neutralizing broth) for 30 seconds and then put into Tryptic Soy Broth (TSB) -30 containing glass tubes for 24 hours. At the end of 24 hours the tubes containing the penicylinders were evaluated for turbidity and scored as either growth or no growth. Ten hollow glass cylinders were tested per formulation. If 0 out of 10 tubes showed no growth, the formulation was-rated "Pass." If more than I tube out of 10 tubes showed 5 growth, the formulation was rated "Fail." Table 3. Antimicrobial formulations effect on Pseudomonas (ATCC 9027) Comp. Comp. Comp. Comp. Comp. Comp. Table 3 Ex. C1 Ex. C2 Ex. C3 Ex. C41Ex. C5Ex. C6 Ex. 1 Ex. 2 Ex. 3 Formulation 2 3 4 5 6 7 8 9 10 Fail tubes/ 9/10 7/9 6/9 2/10 2/10 10/10 0/10 0/10 0/10 total tubes Rating Fail Fail Fail Fail Fail Fail Pass Pass Pass Table 4. Antimicrobial formulation effect on MRSA (ATCC# 33593) Table 4 Conip. Ex. C7 Comp. Ex. C8 Example 4 Formulation Formulation Formulation 11 12 13 Failed tubes /total tubes 2/10 3/10 0/10 Rating Fail Fail Pass 10 Examples 5-7 and Comparative Examples C9-C 10: Treatment of ground beef Antimicrobial efficacy using Lactoferrin and Nisin as additional enhancers for ground beef treatment was evaluated., 15 Detenination of the native bacteria counts on ground beef Ground beef purchased from the grocery store was tested immediately for native bacteria count by placing 1I-gram (1 1-g) portions of the ground beef into separate Homogenizer Bag filtered #6469(3M, St. Paul, MN) with 99 milliliters (mL) of Letheen Broth (VWR Scientific, Batavia, IL) in each and stomached for 1 minute in 20 a laboratory blender Stomacher 400 (Telanar, Cincinnati, OH). Serial ten-fold sequential dilutions were made with Letheen broth. Samples were plated on PETRIFILM Enterobacteriaceae count plate (EB) (available from 3M, St. Paul, MN) and PETRIFILM Aerobic Count (AC) plate (available from 3M, St. Paul, MN). PETRIFILM plates were incubated for 24 +/- 2 hours at 35 0 C and counted as -31 recommended on the package insert. Plates with counts that were within the counting range of the plates (25-250 CFU per PETRIFILM AC plate and 15-100 CFU per p PETRIFILM EB plate) were used for analysis. 5 Formulation preparation and meat treatment A concentrate of antimicrobial lipid (Concentrate 2) was made by adding the components listed in the Table 5 below into a glass container. The container was heated on a hot plate to 50-80 "C, and during heating the solution was constantly stirred (either by a magnet or a propeller stirring system). The solution was mixed until a 10 homogenous, transparent, single-phase liquid resulted. This concentrate was used to treat the ground beef samples. Table 5 Concentrate 2 GML12 15.0 PGMC8 45.0 Pationic 122A 10.0 Span 20 15.0 DOSS 3.0 BHA 2.0 Benzoic Acid 10.0 The ground beef samples were treated with a two part system - Part A and Part B. Part A consisted of Concentrate 2 diluted in water to 40 wt-% and Part B consisted 15 of an aqueous enhancer solution made by dissolving either 10 wt-% Lactoferrin or 1.6 wt-% Nisin in water or both 10 wt-% Lactoferrin and 1.6 wt-% Nisin in water. Weighed amounts of ground beef were added into the KITCHEN-AID mixer equipped with a paddle mixing head. The Part B solution was placed in a pressure pot (23 C) connected to a spray nozzle. The solution was sprayed into the ground beef 20 (5"C) contained in the mixer while mixing occurred with the paddle mixer. The sprayed meat contained about 2.5 wt-% of the aqueous solution. This delivered 0.25 wt-% Lactoferrin and/or 0.04 wt-% Nisin (800 IU) to the groumd beef in 1.5 minutes (min). Samples were then sprayed with Part A (40:wt-% Concentrate 2). The sprayed meat contained about 2.5 wt-% aqueous solution (1 wt-% Concentrate 2 delivered into the 25 meat samples). The total mixing time was 3 minutes. The treated ground beef samples were placed in the refrigerator again. Five sets of treatments were applied to the -32 ground meat with the above-described spraying procedure. After the spray and mixing, the final weight percent in meat for each treatment was as listed in the Table 6 below. Table 6. Final component weight percentages in meat for Examples 5-7 and Comparative Examples 9 & 10 Comp. Ex. Comp. Ex. Table 6 C9 Ex. 5 Ex. 6 Ex. 7 CIO Diluted Diluted . Concentrate Diluted Concentrate Diluted 2 Concentrate 2 Concentrate with Lactoferuin 2 with 2 Lactofein and Nisin Only Lactofen-in with Nisin and Nisin Only Solution pH 4.5 5.5 5.5 5,5 5.5 GMLC12 0.150 0.150 0.150 0.150 PGMC8 0.450 0.450 0.450 0.450 Pationic 122A 0.100 0.100 0.100 0.100 Span 20 0.150 0.150 0.150 0.150 _ DOSS 0.030 0.030 0.030 0.030 Beanzoic Acid 0.100 0,100 0.100 0.100 BHA 0.020 0.020 0.020 0.020 Lactoferrin 0.250 0.250 0.250 5 ~ Nisin .4a.4 No color change was observed in any of these samples over the course of storage. After 24 hours, an 11-g aliquot of ground beef was weighed out and placed into Homogenizer Bag filtered with 99 mL of Letheen broth added to the samples bag. The sample in bag was stomached for 30 seconds to assist with removal of bacteria .0 from meat. The stomached solution was ten-fold sequentially further diluted by transferring 1 mL into 9 mL the Letheen broth. Each diluted solution was analyzed using PETRIFILM AC and PETRIFILM EB as media. Plates with counts that are within the -counting range of the plates (25-250 CFU per PETIPJFILM AC plate and 15 100 CFU per PETRIFILM LB plate) were used for analysis. The results were converted 5 to log 10 and the replicates averaged. The results of the treated meat samples were subtracted from the results of the analogous untreated meat samples to determine the log reduction of the treatment. Table 7 shows the data obtained from the tests described above.
fTl LUXoJ.JJUL7 70 rt.IIU LtJU4/UZ241 -33 4 ONN r-n .- m A 6 Inn C)5 N4 Cr 4 0 0 Cfl 6 d) op, pq P4 6,4a " " Um m""rt.- 11 UOhIUUUy4jq -34 The same experiments were repeated 3 times with different batches of meat and similar results were observed. The Examples in Table 7 indicate that at 4 0 C on ground beef, three enhancers (carboxylic acid, bacteriocin, iron-binding protein) provide significant antimicrobial efficacy. This would be expected to extend the 5 shelf-life of the meat without affecting sensory properties. Example 8 Example 5 was repeated with the following noted differences. A pressurized sprayer (Sprayer Systems Co., Wheaton, IL) with a fan nozzle was used. The 10 KITCHEN-AID mixer blehded the combination of Part A (undiluted) and Part B(containing both lactoferrin and nisin) with the paddle attachment for 3 minutes total at a low mix setting. The enhancer, Part B, was delivered first at a spray rate of 30 mL/min during the first 1.5 minutes of mixing. Part A, Concentrate 2, was not diluted in this case and was delivered at a spray rate of 7.5 mL/min while the mixing 15 continued for an additional 1.5 minutes (min). Sufficient enhancer and antimicrobial lipid were added to deliver 1 wt-% of Concentrate 2 and 4 wt-% enhancer solution to the meat. The initial native bacteria was 40-80 counts/gram, detected with PETRFILM AC. Ten minutes after treatment, the native bacteria became undetectable. 20 Examples 9-28 and Comparative Examples C1 1-C15 Antimicrobial liquid compositions (Examples 9-28 and Comparative Examples C 1-C15), having potential utility in the human oral cavity, were prepared by combining the components listed in Tables 8 and 9. Each liquid composition 25 contained water (with 0.5 wt-% PLURONIC P65 surfactant) as a solvent system, two fatty acid monoesters (PGMC8 and GMLC 12), an anionic surfactant (DOSS), optionally an organic acid enhancer (benzoic acid), and anenhancer selected from the group including sucrose, xylitol, lactoferrin, and nisin. Compositions without a secondenhancer (i.e., only an organic acid enhancer) were considered as Controls 30 (designated with letter C), v W urciioUT2004/U29241 -35 Table 8: Antimicrobial Compositions Component Bxample (Grams) C11 9 10 11 12 C12 13 14 15 16 Water with 0.5% PLURONIC P65 100 100 100 100 100 100 100 100 100 100 PGMC8 0.03 0.03 0.03 0.03 0.03 0.3 0.3 0.3 0.3 0.3 GMLC12 0.03 0.03 0.03 0.03 0.03 0.3 0.3 0.3 0.3 0.3 DOSS 0.02 0.02 0.02 0.02 0.02 0.2 0.2 0.2 0.2 0.2 Sucrose 1 1 Xylitol 1 1 Lactoferrin 1 Nisin 0.15 0.15 Wt-% (PGMC8 + GMLC12 + DOSS) 0.08 0.08 0.08 0.08 0.08 0.8 0.8 0.8 0.8 0.8 5 VV~ tU/~jY ci UYU~i1EJ4/2924 1 -3- 0D -4 O -4 -4 0D CIA 0) 0 0 0 1.4 6666 6- -4 66 6 00 u 0 78 rr 0 0 0 CDN' 0D C~) C ; q~ CD 000 C -4 cn ) 0 C) 00 0 Mn e N n 0 00D.0CD en c ce q S C C) C) 6 0 -4 oo66 )0 o 0 00 u> C 13 0 N C r". I/,U 1UWU4/VY41 -37 Evaluations and Results The antimicrobial compositions (Examples 9-28 and Comparative Examples C11 -C15) were evaluated for antibacterial activity according to the Antibacterial (Streptococcus inutans) Kill Rate Test Method as follows. Results areprovided in 5 Table 10. Antibacterial (Streptococcus mutans) Kill Rate Test Method. A sample of 0.1 mL of S. mutans (ATCC # 25175) at 108 CFU/ml in brain heart infusion (BHI) broth was mixed with 19.9 mL of liquid test antimicrobial 10 sample at a given concentration in water for a predetermined time (0.5 minute, 2 minutes, 5 minutes, and 10 minutes each). Immediately after mixing for the predetermined time, 1.0 mL of the sample was transferred from the flask into a test tube containing 9.0 mL Letheen Broth (VWR Scientific, Batavia, IL) to neutralize for the fatty acid monoester and benzoic acid components that might be present in 15 the sample. A Vortex mixer was used for thorough mixing and the resulting solution was designated as the 10- dilution. A 1. 0-mL aliquot was transferred from the 10-1 dilutiori into a second tube containing 9.0 mL Letheen Broth and mixed as above to give a solution designated the 10-2 dilution. Alicjuots (0.1 mL) from each of the 10 and 10-2 dilutions were plated out in duplicate and spread on sheep blood agar with 20 hockey-stick applicators on Petri dish plates to provide 10-2 and 10- concentrations on each respective plate. The Petri dishes were incubated for 96 hours at 37"C aerobically followed by counting the number of colony forming units (CPU). This information was used to compute kill rates for S. mutans at a specified concentration of test sample. 25 wu ZU3IUZYY5PCT/US2004/029 241 -38
------------------------
'~cjo t0 O \ O 00~i 00 i 00 0 ti r e n . l A 4qcI4It t t 0 cq cd c + 0 C:C 4-044 0I 44' * 'iI ' * 0 424 0 V" q -- t c 0 0 4 rr rH Q Q 4e r lxl -4 wu PC1/U S200J4/029241 -39 00 00 inl 00 00 CD 6; C: , 00 00 0 0 00 000 n00 0 00 0 -- 2 . 0 00 0 0 a)Nr0o woc -C l C r- N l C C) -40 It can be concluded from the data in Table 10 that, in general, the antimicrobial composition that contained the organic acid enhancer (benzoic acid) and the antimicrobial compositions that contained both organic acid enhancer and enhancer showed the greatest levels of S. mutans log reduction. 5 Various modifications and alterations to this invention will become apparent to those skilled in the art without departing from the scope and spirit of this invention. It should be understood that this invention is not intended to be unduly limited by the illustrative embodiments and examples set forth herein and that such examples and 10 embodiments are presented by way of example only with the scope of the invention intended to be limited only by the claims set forth herein as follows. Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and variations such as "comprises" or 15 "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps. The reference in this specification to any prior publication (or information derived 20 from it), or to any matter which is known, is not, and should not be taken as an acknowledgment or admission or any form of suggestion that that prior publication (or information derived from it) or known matter forms part of the common general knowledge in the field of endeavour to which this specification relates.
Claims (59)
1. An antimicrobial composition, comprising: an antimicrobial lipid component comprising a compound selected from the 5 group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof; and an enhancer component comprising a compound selected from the group consisting of iron-binding proteins and derivatives thereof, siderophores, and combinations thereof 10
2. The composition of claim 1 further comprising a surfactant.
3. The composition of claim I wherein the antimicrobial lipid component comprises a (C7 to C14)fatty acid ester. 15
4. The composition of claim 1 wherein the enhancer component further comprises at least one other enhancer of at least one different class of compound.
5. The composition of claim 4 wherein the enhancer component further 20 comprises at least two other enhancers of at least two different classes of compound.
6. The composition of claim 1 wherein the enhancer component further comprises an enhancer selected from the group consisting of bacteriocins, antimicrobial enzymes, sugars, sugar alcohols, and combinations thereof. 25
7. The composition of claim 6 wherein the enhancer component comprises nisin and lactoferrin or derivatives thereof.
8. The composition of claim 7 wherein the enhancer component comprises 30 nisin, lactoferrin, and either a sugar, a sugar alcohol, or both.
9. The composition of claim 1 which demonstrates at least a one-log average reduction of total aerobic bacteria count. . -- 42
10. The composition of claim 1 in the form of a dental composition.
11. An antimicrobial composition, comprising: 5 an antimicrobial lipid component comprising a compound selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof; and an enhancer component comprising an organic acid or phenolic compound and a compound selected from the group consisting of bacteriocins, antimicrobial 10 enzymes, sugars, sugar alcohols, iron-binding proteins and derivatives thereof, siderophores, and combinations thereof.
12. The composition of claim 11 wherein the enhancer component comprises an organic acid, lactoferrin, and either a sugar, a sugar alcohol, or both. 15
13. The composition of claim 12 wherein the sugar is a mono- or di-saccharide.
14. The composition of claim 13 wherein the sugar is a monosaccharide selected from the group consisting of mannose, xylose, maltose, sorbose, and combinations 20 thereof
15. The composition of claim 12 wherein the sugar alcohol is selected from the group consisting of mannitol, xylitol, maltitol, sorbitol, and combinations thereof 25
16. The composition of claim 12 wherein the organic acid enhancer is benzoic acid.
17. The composition of claim 11 further comprising a surfactant. 30
18. The composition of claim 11.wherein the antimicrobial lipid component comprises a (C7 to C14)fatty acid ester. -465
19. The composition of claim 11 in the form of a dental composition.
20. An antimicrobial composition, comprising: an antimicrobial lipid component comprising a compound selected from the 5 group consisting of a (C7-C14)fatty acid ester, an-unsaturated fatty acid ester of a polyhydric alcohol, a saturated fatty ether of a polyhydric alcohol, an unsaturated fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof, wherein the alkoxylated derivative has less than 5 moles of alkoxide per mole of polyhydric alcohol; with the proviso that the antimicrobial lipid 10 does not include a glycerol monoester; and an enhancer component comprising a compound selected from the group consisting of bacteriocins, antimicrobial enzymes, sugars, sugar alcohols, iron binding proteins and derivatives thereof, siderophores, and combinations thereof. 15
21. The composition of claim 20 wherein the enhancer component comprises a compound selected from the group consisting of sugars, sugar alcohols, or combinations thereof.
22. The composition of claim 20 wherein the enhancer component does not 20 include nisin.
23. The composition of claim 20 wherein the enhancer component comprises lactoferrin. 25
24. The composition of claim 20 further comprising a surfactant.
25. The composition of claim 20 wherein the antimicrobial lipid component comprises a (C7 to C14)fatty acid ester. 30
26. The composition of claim 20 wherein the antimicrobial lipid component comprises a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, or combinations thereof. -44
27. The composition of claim 20 which demonstrates at least a one-log average reduction of total aerobic bacteria count. 5
28. The composition of claim 20 in the form of a dental composition.
29. The composition of claim 20 wherein the antimicrobial lipid component is present in the composition in a major amount. 10
30. An antimicrobial, composition, comprising: an antimicrobial lipid component comprising a compound selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof; with the proviso that the antimicrobial lipid component does not include a glycerol 15 monoester; and an enhancer component comprising a compound selected from the group consisting of mannose, xylose, mannitol, xylitol, and combinations thereof.
31. An antimicrobial composition, comprising: 20 an antimicrobial lipid component comprising a compound selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof; with the proviso that the antimicrobial lipid component does not include a glycerol monoester; and 25 an enhancer component comprising a compound selected from the group consisting of bacteriocins, antimicrobial enzymes, sugars, sugar alcohols, iron binding proteins and derivatives thereof, siderophonres, and combinations thereof; wherein the pH of the composition is no higher than 6. 30
32. An antimicrobial kit, comprising: a first container comprising an antimicrobial lipid component comprising a compound selected from the group consisting of a fatty acid ester of a polyhydric -45 alcohol, a fatty ether of a polyhydric alcohol, alkoxylated derivatives thereof, and combinations thereof; and a second container comprising an enhancer component comprising a compound selected from the group consisting of bacteriocins, antimicrobial 5 enzymes, sugars, sugar alcohols, iron-binding proteins and derivatives thereof, siderophores, and combinations thereof
33. A method of using the composition of claim 1, the method comprising applying the composition of claim I to a surface. 10
34. The method of claim 33 wherein the surface is the surface of a substrate selected from the group consisting of meat, meat products, plants, and plant parts.
35. The method of claim 33 wherein the surface is the surface of an inanimate 15 substrate selected from the group consisting of textiles, glass, polymeric surfaces, metal, wood, and rubber.
36. The method of claim 33 wherein the surface is the surface of skin or hair of a mammal. 20
37. The method of claim 33 wherein the surface is the surface within the oral cavity of a mammal or the surface of a dental product.
38. The method of claim 37 wherein the surface within the oral cavity of a 25 mammal is a dental structure surface.
39. The method of claim 33 further comprising diluting the composition with a vehicle before applying the composition to a substrate. 30
40. A method of using the composition of claim 11, the method comprising applying the composition of claim 11 to a surface. -46
41. The method of claim 40 wherein the surface is the surface of a substrate selected from the group consisting of meat, meat products, plants, and plant parts.
42. The method of claim 40 wherein the surface is the surface of an inanimate 5 substrate selected from. the group consisting of textiles, glass, polymeric surfaces, metal, wood, and rubber.
43. The method of claim 40 wherein the surface is the surface of skin or hair of a mammal. 10
44. The method of claim 40 wherein the surface is the surface within the oral cavity of a mammal or the surface of a dental product.
45. The method of claim 44 wherein the surface within the oral cavity of a 15 mammal is a dental structure surface.
46. The method of claim 40 further comprising diluting the composition with a vehicle before applying the composition to a substrate. 20
47. A method of using the composition of claim 20, the method comprising applying the composition of claim 20 to a surface.
48. The method of claim 47 wherein the surface is the surface of a substrate selected from the group consisting of meat, meat products, plants, and plant parts. 25
49. The method of claim 47 wherein the surface is the surface of an inanimate substrate selected from the group consisting of textiles, glass, polymeric surfaces, metal, wood, and rubber. 30
50. The method of claim 47 wherein the surface is the surface of skin or hair of a mammal.
51. The method of claim 47 wherein the surface is the surface within the oral cavity of a mammal or the surface of a dental product.
52. The method of claim 51 wherein the surface within the oral cavity of a 5 mammal is a dental structure surface.
53. 'The method of claim 47 further comprising diluting the composition of claim 47 with a vehicle before applying the composition to a substrate. 10
54. A method of using the composition of claim 30, the method comprising applying the composition of claim 30 to a surface.
55. A method of using the composition of claim 31, the method comprising applying the composition of claim 31 to a surface. 15
56. A method of applying an antimicrobial composition to a substrate, the method comprising applying to the substrate a major amount of an antimicrobial lipid component comprising a compound selected from the group consisting of a fatty acid ester of a polyhydric alcohol, a fatty ether of a polyhydric alcohol, 20 alkoxylated derivatives thereof, and combinations thereof; and applying to the substrate a minor amount of an enhancer component comprising a compound selected from the group consisting of bacteriocins, antimicrobial enzymes, sugars, sugar alcohols, iron-binding proteins and derivatives thereof, siderophores, and combinations thereof 25
57. The method of claim 56 wherein the antimicrobial lipid component is applied to the substrate before the enhancer component is applied to the substrate.
58. The method of claim 56 wherein the antimicrobial lipid component is applied 30 to the substrate after the enhancer component is applied to the substrate.
59. The method of claim 56 wherein the antimicrobial lipid component and the enhancer component are applied in the form of a ready-to-use formulation comprising a major amount of a propylene glycol fatty acid ester that contains at least 60% fatty acid monoester, a minor amount of an enhancer, and optionally a 5 surfactant, wherein the concentration of the propylene glycol fatty acid ester is greater than 30 wt-% of the ready-to-use formulation and the concentration of the enhancer is 0.1 wt-% to 30 wt-% of the ready-to-use formulation. 10.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2013211535A AU2013211535A1 (en) | 2003-09-09 | 2013-08-02 | Antimicrobial compositions and methods |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/501,817 | 2003-09-09 | ||
AU2011201338A AU2011201338A1 (en) | 2003-09-09 | 2011-03-23 | Antimicrobial compositions and methods |
AU2013211535A AU2013211535A1 (en) | 2003-09-09 | 2013-08-02 | Antimicrobial compositions and methods |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2011201338A Division AU2011201338A1 (en) | 2003-09-09 | 2011-03-23 | Antimicrobial compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2013211535A1 true AU2013211535A1 (en) | 2013-08-22 |
Family
ID=48986407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2013211535A Abandoned AU2013211535A1 (en) | 2003-09-09 | 2013-08-02 | Antimicrobial compositions and methods |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2013211535A1 (en) |
-
2013
- 2013-08-02 AU AU2013211535A patent/AU2013211535A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1662873B1 (en) | Antimicrobial compositions and methods | |
AU2004270266B2 (en) | Concentrated antimicrobial compositions and methods | |
CA1331559C (en) | Antimicrobial preservative compositions and methods | |
US6921745B2 (en) | Bactericidal composition comprising polylysine and a plant essential oil | |
US4067997A (en) | Synergistic microbecidal composition and method | |
JP6454805B1 (en) | Alcohol preparation and disinfection method using the same | |
US20110028546A1 (en) | Novel antimicrobial formulations incorporating alkyl esters of fatty acids and nanoemulsions thereof | |
EP2846637A1 (en) | Synergistic antimicrobial agents | |
AU2013211535A1 (en) | Antimicrobial compositions and methods | |
TW202214222A (en) | Composition for leave-on-type skin external preparation | |
KR101859924B1 (en) | A cleaning composition containing glyceryl monodecenoate | |
JP4117051B2 (en) | Antibacterial agent for tableware and cooking utensils and antibacterial agent composition for tableware and utensils | |
JP2001064113A (en) | Aqueous solution of chemical for aero spraying for sterilizing, removing or controlling floating fungus and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period | ||
NB | Applications allowed - extensions of time section 223(2) |
Free format text: THE TIME IN WHICH TO REQUEST EXAMINATION HAS BEEN EXTENDED TO 13 MAY 2014 . |
|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |